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Polarized epithelial cell function relies on the proper sorting and distribution of newly 
synthesized proteins to either the cells apical or basolateral domains. If trafficking is altered by 
disruptions either the fidelity or efficiency of this sorting then disease can result. There is an 
increasing appreciation for the role of phosphatidylinositol metabolism in membrane traffic, 
including the sorting and delivery of newly synthesized proteins. I have studied how biosynthetic 
delivery pathways are regulated by the expression of phosphatidylinositol-metabolizing 
enzymes. The phosphatidylinositol 4,5-bisphosphate (PIP2)-synthesizing enzyme, murine 
phosphatidylinositol 4-phosphate 5-kinase I alpha (PI5KIα) localizes to the apical pole of Madin-
Darby canine kidney (MDCK) cells and increases cellular PIP2 concentrations over control cell 
levels. Interestingly, expression of exogenous PI5KIα stimulated the rate of surface delivery of a 
subset apical proteins that associate with lipid rafts, including influenza hemagglutinin (HA). 
Conversely, overexpression of the PIP2-5’-phosphatase OCRL (oculocerebrorenal syndrome of 
Lowe), which is defective or absent in patients with Lowe syndrome, decreased cellular PIP2 
levels and inhibited the rate of HA delivery.  
The observation that increases in PIP2 stimulate apical delivery of HA suggests the 
possibility that depletion of OCRL may have a similar effect to overexpression of PI5K. I used 
siRNA to knock down OCRL in MDCK cells and human proximal tubule (HK2) cells and 
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examined the consequence on HA surface delivery. Knockdown of OCRL slightly increased 
cellular PIP2 levels but did not stimulate HA delivery.  
PI5K-mediated increases in PIP2 results in activation of neuronal Wiskott-Aldrich 
syndrome protein (N-WASP) leading to downstream actin cytoskeleton rearrangements 
including the formation of actin comets. To examine the potential role of N-WASP in HA 
delivery I expressed a dominant negative inhibitor of N-WASP function, the WA domain from a 
WASP family member, WAVE1. Expression of the WA domain significantly and selectively 
inhibited the rate of HA surface delivery. siRNA-mediated knockdown of N-WASP also 
inhibited HA delivery, confirming a role for N-WASP in biosynthetic traffic. Consistent with 
this, PI5KIα and HA (but not p75) were visualized on actin comets in formaldehyde-fixed 
MDCK cells. In summary, my data support a role for PI5K-stimulated actin comet formation in 
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1.0     INTRODUCTION 
1.1 OVERVIEW 
The function of polarized epithelial cells depends largely on their ability to maintain a barrier 
between internal and external environments, as well as their ability to perform specialized tasks, 
including ion transport across the barrier or binding to surface-specific ligands. Barrier function 
is maintained by a series of junctional proteins surrounding cells giving them a cobblestone 
appearance and preventing paracellular flow of solutes (Figure 1.1). Tight junctions also prevent 
the intramembranous flow of proteins and lipids dividing the membrane into two distinct 
domains: apical (luminal; green in Figure 1.1) and basolateral (ablumenal; orange in Figure 1.1). 
Because polarized epithelial cells have two separate membrane domains, they must accurately 
deliver and maintain proteins at their appropriate sites of function. My work concentrates on the 
role of lipids in the delivery of newly synthesized proteins to the plasma membrane, termed 
biosynthetic traffic.  
The plasma membrane is composed of a diverse array of lipids that provide it with 
structural and functional attributes. An important class of lipids is the phosphatidylinositol 
phosphates (PIPs), which exist in many different varieties due to multiple phosphorylation 
arrangements. These lipids have important roles in cellular signaling and regulation of membrane 
traffic. One mechanism by which they affect membrane traffic is through interacting with 
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proteins that modulate actin cytoskeletal dynamics. Actin is broadly important as a structural 
component of cells, but it also has a crucial role in the movement of vesicles. My primary goal 
was to determine if there is a role for PIP metabolism in polarized biosynthetic traffic and if so, 
to determine if actin is directly involved. The following introduction provides the framework 
with which to put my studies into perspective with the current literature on PIPs and polarized 




































Figure 1.1 Renal tubule cells and a schematic of a polarized epithelial cell. 
 
The top panel is a cross section of stained kidney tubules from the Indiana 
University online histology tutorial. Collecting duct (cd) segments, the thin 
(descending) and thick (ascending) limbs of the loop of Henle, and a renal 
vein (vr) are labeled. The bottom panel is a schematic drawing of polarized 
epithelial cells with the apical (green) and basolateral (orange) surfaces 
highlighted. Highly glycosylated proteins (blue) decorate the apical surface of 
these cells forming a protective barrier (glycolcalyx). Also depicted are the 
nucleus (yellow) ER (grey) studded with ribosomes (black spots), Golgi (red) 
and trans-Golgi network (pink). Arrows depict the direction of movement for 
biosynthetic traffic from ER to Golgi to cell surface. Note how the cells are 
arranged in the kidney tubule and how this orientation relates to the polarized 
cell schematic. 
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1.2 BIOSYNTHETIC TRAFFIC: THE ENDOPLASMIC RETICULUM AND 
BEYOND 
The biosynthetic sorting of proteins begins immediately upon protein synthesis. Cytosolic 
proteins are synthesized in the cytoplasm, while nascent proteins containing a hydrophobic 
signal sequence are recognized by a signal recognition particle (SRP) and shuttled to the 
endoplasmic reticulum (ER). Coincident with their translation, transmembrane proteins are 
inserted into the lipid bilayer, while secreted proteins are deposited in the ER lumen. ER-resident 
chaperones sense the folding state of the newly synthesized protein to determine whether it is fit 
for delivery. Misfolded proteins are candidates for ER associated degradation (ERAD) via the 
proteasome (1). During/after co-translational insertion into the ER, proteins can be altered by 
post-translational modifications and assembled into multisubunit oligomeric protein complexes.   
Non-ER resident proteins exit the ER via a mechanism dependent upon the coat protein 
complex II  (COP II) (2). COP II contains the components necessary for formation and release of 
a vesicle from an ER exit site. COPII consists of Sec 23/24, Sec 13/31, and the small GTPase 
Sar1. Sec 23/24 form the cargo recognition component of the coat and are recruited to the ER 
membrane by GTP-bound Sar1.  The Sec13/31 complex is subsequently recruited to the ER and 
forms a cage that promotes vesicle budding. Uncoating of the vesicle occurs when COP II 
components stimulate the GTPase activity of Sar1, which prepares the vesicle for future fusion 
events (3). After exiting the ER, proteins transit through the ER-to-Golgi intermediate 
compartment (ERGIC) before reaching the flattened cisternae of the Golgi complex. The ERGIC 
is a major site of both anterograde (forward) and retrograde (reverse) traffic between the ER and 
Golgi and is thought to contribute to both protein folding and quality control (4).  
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Proteins are further processed in the Golgi complex before packaging and delivery to the 
plasma membrane. In this compartment proteins can be cleaved by proteases and undergo 
processing of core N-glycans added to them in the ER. O-glycans are also added and extended in 
this organelle. After reaching the trans-Golgi network (TGN) proteins may be delivered to the 
plasma membrane by either a direct or indirect pathway. The TGN was long thought to be the 
primary site at which targeting information within proteins was recognized and translated into 
delivery instructions. However, recent evidence suggests that some proteins take an “indirect 
pathway” and traverse endosomal compartments en route to the cell surface (5-7). The 
observation that biosynthetic cargo also intersects with these compartments raises the possibility 
that sorting of some proteins may occur in endosomes.  
Polarized epithelial cells are unique because they require additional sorting to their two 
distinct membrane domains. Wherever the site of biosynthetic sorting, several signals have been 
identified that are important for polarized delivery. For basolateral proteins, sorting information 
is most often found within the cytoplasmic tail of the protein, ideal for recognition by 
cytoplasmic sorting machinery. Apical sorting signals are more pleomorphic, and include 
lumenal N- and O-linked carbohydrates, transmembrane domains, lipid anchors, and cytoplasmic 
peptide motifs. A common sorting mechanism for these diverse signals is difficult to envision; 
therefore the possibility exists for multiple transport mechanisms. Some data suggest that diverse 
classes of apical proteins take different pathways to the cell surface (7-9). However, the 
trafficking machinery involved for each apical pathway has yet to be determined.  
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1.2.1 Basolateral Sorting in Polarized Epithelial Cells 
Basolateral proteins contain short linear peptide motifs that are recognized by the 
heterotetrameric adaptor protein (AP) complexes. Four AP complexes have been identified: AP-
2 for endocytosis, and AP-1, AP-3, and AP-4, which are localized to the TGN and endosomal 
compartments where they can interact with different signals (10). Basolateral sorting by AP 
complexes can be conferred by the tyrosine-base tetrapeptide motif YXXΦ or by a dileucine 
motif, [D/E]XXXL[L/I] among others. These signals not only function as basolateral targeting 
signals, but can also function as sorting signals for endocytosis and lysosomal delivery (11). Of 
particular interest, there is an epithelial specific isoform of the AP-1 µ subunit (µ1-B). AP1B 
complexes containing this subunit are required for efficient sorting of the basolateral proteins 
transferrin (Tfn) receptor and low-density lipoprotein (LDL) receptor in polarized LLC-PK1 
cells  (12;13). The ability of AP complexes to interact with both cargo and clathrin allows 
proteins to be concentrated in clathrin coated vesicles (CCVs), facilitating their delivery to the 
basolateral surface. Additionally, clathrin itself has been shown to be indispensible for the 
polarized delivery of basolateral proteins, as demonstrated by their apical missorting upon RNA 
interference (RNAi) of clathrin (14).  
1.2.2 Apical Sorting in Polarized Epithelial Cells 
Polarized epithelial cells must be able to recognize and sort the diverse apical sorting signals 
presented by proteins. Some apical proteins, such as rhodopsin and the renal scavenger receptor 
megalin contain cytoplasmic peptide motifs that are important for their apical delivery (15;16). 
Addition of O-linked and N-linked glycosylation is necessary for the apical sorting of proteins 
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like the neurotrophin receptor, p75 and the sialomucin endolyn, respectively  (17;18). Finally, 
sorting of some apical proteins depends on their association with the lipid bilayer. This is the 
case for some proteins modified by glycophosphatidylinositol (GPI) anchors (e.g. placental 
alkaline phosphatase) as well as for some transmembrane proteins that contain apical sorting 
information within their transmembrane domain, such as influenza hemagglutinin (HA) and 
neuraminidase (NA) (19;20). It is plausible that receptor-mediated sorting is used for peptide- 
and glycan-dependent signals; however, this mechanism is less likely for proteins whose apical 
targeting is lipid-dependent. A potential mechanism for sorting of proteins with lipid-dependent 
signals is selective inclusion of these proteins into sphingolipid-enriched detergent-resistant 
microdomains termed lipid rafts.  
In 1988 Kai Simons proposed a model stating that the asymmetric lipid distribution of 
polarized epithelial cells is established by lateral segregation of lipids into microdomains 
destined for either the apical or basolateral surface (21). Support for this model came in 1992 
when Deborah Brown demonstrated that GPI-anchored proteins can be isolated in glycolipid-
enriched low density membranes, later termed lipid rafts (22). Lipid rafts have since been 
reported to play important roles in signal transduction, cytoskeletal organization, pathogen entry, 
and membrane traffic (23). However, the existence of these domains has been challenged largely 
due to the inability to visualize them in living cells, to inconsistency in their predicted size, and 
to the controversial methods used to test for raft function, such as acute cholesterol depletion 
(24). Lipid raft-association of a given protein is best determined by gradient centrifugation and 
largely relies on the characteristic insolubility of rafts in non-ionic detergents and their low 
buoyant density.  While the size and dynamics of rafts continue to be elusive, it is clear that a 
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protein’s ability to partition with raft membranes does provide relevant information about the 
trafficking of that protein (25). 
Both GPI-anchored proteins and HA have been demonstrated to associate with lipid-rafts, 
as assessed by their characteristic insolubility in cold Triton X-100 (26;27). Lipid-rafts have been 
implicated in sorting of proteins to the apical plasma membrane of polarized epithelial cells  
(28;29). Lipid-rafts are highly concentrated in sphingolipids with saturated fatty acid side chains 
and cholesterol allowing them to pack tightly and serve as both signaling and sorting platforms 
(29;30). The lipid phosphatidylinositol 4,5-bisphosphate (PIP2) has been proposed to be enriched 
in rafts, however the presence of PIP2 in rafts has been challenged (31). Hydrolysis of PIP2 can 
contribute to membrane traffic and signaling cascades by producing second messengers such as 
inositol trisphosphate (IP3) and diacylglycerol (DAG) (32-34). Given the fact that some apical 
proteins partition into lipid rafts, it is tempting to speculate that PIP2 may be important for the 
traffic of some apical proteins, but a relationship between these phenomenon has not been 
discovered. 
1.3 PHOSPHATIDYLINOSITOLS AND THEIR METABOLISM 
PIPs are inner leaflet lipids anchored in the membrane by a diacylglycerol tail, which is linked 
via a phosphodiester to an inositol sugar headgroup (Figure 1.2) (35). Phosphatidylinositol (PI) is 
made in the ER and is transported throughout the cell via vesicular transport or by PI transfer 
proteins (36). The inositol headgroup contains five free hydroxyl groups, and the 3’, 4’ and 5’ 
positions are differentially phosphorylated to produce a diverse array of PIP species (37). The 
versatility of PIPs contributes to myriad cellular functions, including cell signaling, regulation of 
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ion channels, and membrane trafficking. Cells specifically localize PI kinases and PI 
phosphatases to maintain a compartmentalized distribution of PIPs. Below I discuss the cellular 
localization of the major PIP species, as well as the enzymes that are responsible for their 
synthesis and degradation. 
1.3.1 Phosphatidylinositol Localization 
In order to accurately study the function of PIPs, it is important to know their steady state 
subcellular localization. This has been difficult as PIPs exist at low abundance and are turned 
over rapidly. In vitro, cellular PIPs can be extracted and analyzed by thin layer chromatography 
(TLC), high pressure liquid chromatography (HPLC), and mass spectroscopy, but within cells 
identification is more complicated (38). Much of what is known about the cellular localization of 
these lipids comes from work employing high specificity probes such as conserved PIP binding 
domains (to be discussed in Chapter 1.4.2.1). These domains have allowed researchers to 
determine the steady state intracellular distribution of individual PIP species (Figure 1.3) (39).  
PIPs are compartmentalized within cells and their general steady state distributions and 
basic functions are detailed in the sections to follow (Figure 1.3). Phosphatidylinositol 3-
phosphate (PI3P) is localized primarily to endosomes and lysosomes. PI3P is thought to provide 
organellar identity to early endosomes, but it also participates functionally in tethering, fusion, 
signaling, and motility (36). In contrast, phosphatidylinositol 4-phosphate (PI4P) is found 
primarily in the Golgi complex. Golgi-localized PI4P has been shown to participate either 
directly or indirectly in membrane trafficking through the actions of various effector molecules. 
PI4P recruits AP-1, lipid-transfer proteins, such as four-phosphatase-adaptor proteins 2 (FAPP2), 
and other proteins greatly influencing membrane traffic from the Golgi (40).  
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Most of the cellular PIP2 is localized at the plasma membrane, where it functions in 
cellular signaling and endocytosis (36;41). However, evidence suggests that there is also a minor 
pool PIP2 in the Golgi complex. First, it has been demonstrated that PIP2 can be formed on 
isolated Golgi membranes in vitro (42). Second, immunoelectron microscopy studies using the 
PIP2 binding domain of phospholipase C (PLC) have detected a small pool of PIP2 in the Golgi 
(43). Finally the PIP2-hydrolyzing enzyme OCRL localizes primarily to the TGN (in addition to 
coated pits, and endosomes) suggests the availability of substrate at that site  (44). While these 
data hint that a pool of PIP2 is present in the Golgi, the role of PIP2 in polarized biosynthetic 
traffic is uncertain. In chapter 2, I modulate cellular PIP2 levels in order to determine the 
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Figure 1.2 Structural diagram of phosphatidylinositol. 
 
 
The diacylglycerol tail anchors the PIP into the membrane 
and may contain unsaturated carbons (as depicted). A 
phosphodiester link connects the tail to the inositol 
headgroup which can be phosphorylated at the D3, D4, or 
D5 positions on the inositol ring. Figure taken from Irvine 
et al. 2002, full reference in text.  
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PIP2 at the plasma membrane functions in recruitment of endocytic machinery. PI3P is localized 
mainly to the endosomal system and is important for multivesicular body formation. PI4P is 
primarily found within the Golgi complex and a small pool of PIP2 has been localized the Golgi 
as well. The question mark (?) refers to possible localization of PIP2 on post-Golgi vesicles and 
the potential role for actin in their movement (to be discussed later). Figure adapted from De 
Mateteis et al. 2004, full reference in the text. 
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1.3.2  Phosphatidylinositol Kinases 
Cells maintain their steady state distribution of PIPs by compartmentalizing their synthesis via 
PI-kinases. PIP-synthesizing enzymes are classified based on the substrate they act upon and the 
product they generate. These enzymes fall into three general families, phosphatidylinositol 3-
kinases (PI3Ks), phosphatidylinositol 4-kinases (PI4Ks), and phosphatidylinositol 5-kinases 
(PI5Ks). These kinases are present and conserved throughout higher and lower eukaryotes 
suggeststheir importance to cell physiology (45). Table 1.1 and Figure 1.4 show some of the 
kinase and phosphatase isoforms, their localization, substrate specificity, and the reactions they 
catalyze (39). 
PI3Ks are a diverse group of enzymes involved in numerous signaling and trafficking 
processes. PI3Ks were first identified by their interaction with oncoproteins and cellular growth 
factor receptors (45). More broadly, they are implicated in cell proliferation and survival, 
membrane ruffling, neurite outgrowth, actin reorganization, and chemotaxis. The PI3K family 
can be further sub-divided into 3 classes based on structure, substrate specificity, and sensitivity 
to the fungal metabolite wortmannin (46). In general, these enzymes contain a domain that 
interacts with a regulatory subunit and a catalytic domain (45). Class I enzymes are the best 
characterized and are sensitive to wortmannin in the nanomolar range (47). Class I PI3Ks and are 
composed of a 110kDa catalytic subunit and an 85kDa regulatory subunit to generate PI3P, 
PI3,4P2, and PI3,4,5P3.  
PI4Ks phosphorylate PI to generate PI4P, which can then be used to produce both 
PI3,4P2 and PI4,5P2. PI4Ks are subdivided into class II and III, each having an alpha and beta 
isoform. The class II enzymes are approximately 55kDa in size and are insensitive to 
wortmannin but sensitive to adenosine (48). The class III enzymes are approximately 210 kDa 
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(α) and 110 kDa (β), and are sensitive to wortmannin in the micromolar range (49). The different 
PI4K isoforms localize to distinct compartments within the cell, including the ER, Golgi, and 
endosomes. PI4KIIIβ localizes to the Golgi complex and plays an important role in biosynthetic 
traffic in polarized epithelial cells. Overexpression of PI4KIIIβ inhibits the rate of TGN-to-apical 
surface delivery of the lipid raft-associated protein HA. Conversely, overexpression of a kinase 
dead version of the enzyme stimulates the rate of delivery of HA (50). These data highlight an 
important role for PIP metabolism within the Golgi. Additionally, since PI4P is a substrate for 
production of PIP2 the possibility exists that regulated PIP2 metabolism in the Golgi may also be 
important for polarized biosynthetic traffic.  
There are three isoforms of the Type I PI5Ks, which phosphorylate PI4P at the D5 
position to generate PIP2 (53). The alpha and beta isoforms were cloned in 1996 in both human 
and mouse, but they were unfortunately named in reciprocal manner (51;52). I use murine 
PI5KIα in my studies; therefore I have used the mouse nomenclature throughout. This enzyme is 
equivalent to human PI5KIβ. The PI5K gamma isoform was cloned in 1998 and found to have 
two splice variants, a short isoform (PI5KIγ635) and a longer isoform (PI5KIγ661) with a 26 
amino acid insertion near the carboxy-terminal end that can target it to focal adhesions (53;54). 
The central kinase domain of the three isoforms is highly conserved, with greater than 80% 
sequence identity. In vitro, all three isoforms have similar kinetics and are activated by 
phosphatidic acid (PA), ser/thr dephosphorylation, and small GTPases. However, the isoforms 
have divergent amino and carboxy terminal regions that are likely to be responsible for isoform 
specific function and localization (55). PI5Ks are cytosolic proteins, but they can associate with 
the plasma membrane via two invariant lysine residues within the specificity loop and two highly 
conserved basic residues in the kinase domain (55). However, stimulation by GTPases and 
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binding to specific partners has also been shown to enhance their membrane association and 
localization (36;56-58). In nonpolarized cells all three isoforms are found on the plasma 
membrane, but the reason for this redundancy is unknown (59). The functions and localization of 
PI5K isoforms in polarized epithelial cells have been largely unexplored. However, some 
evidence suggests that PI5K isoforms localize to different surfaces in polarized epithelial cells 
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Table 1.1 Activity and localization of PI-kinases and -phosphatases. 
PI-kinase Localization Substrate  PI-phosphatase Localization Substrate 
PI3K 
P110 
PM, N PI4,5P2  PTEN (3-pptase) PM, GC, N PI3,4,5P3 
PI3,5P2 
PI4KIIα GC, E PI  Type I and II 4-
pptase 
E, PM PI3,4P2 
PI4KIIβ PM, GC PI     
PI4KIIIα GC, ER PI  OCRL (5-pptase) CCV,GC,E PI4,5P2 
PI4KIIIβ GC, N PI  Synaptojanin 1 SV, MI PI4,5P2 





Figure 1.4 Summary of known reactions in PIP metabolism and the some of the relevant 
enzymes. 
This figure is a graphic representation of the known PIP metabolism reactions within cells. 
Depicted is the inositol ring and the location of the phosphates for each of the different PIP 
species. The relevant enzymes discussed are labeled above or below the reaction arrows 
depending on the particular reaction they catalyze. Figure adapted from De Matteis et al. 
2004, full reference in text.  
The known localization and in vivo substrate specificity for the discussed PI-kinases and PI-
phosphatases (pptase). Plasma membrane (PM), Golgi complex (GC), endosomes (E), 
endoplasmic reticulum (ER), mitochondria (MI), clathrin coated vesicle (CCV), synaptic vesicle 
(SV), nucleus (N), and not determined (ND). Table adapted from De Matteis et al. 2004, full 
reference in text.  
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1.3.3 Phosphatidylinositol Phosphatases     
The regulation of cellular PIP levels is controlled not only by their synthesis, but by thier 
phosphatase-mediated degradation as well. Naming of the PIP-phosphatases (pptases) does not 
follow the logical convention used for the naming of other enzymes and fails to reveal any 
information about their activity or specificity. PIP-pptases dephosphorylate the inositol ring at 
the 3’, 4’ or 5’ positions to convert PIPs. In general, these enzymes are divided into three 
families based upon the position of the inositol ring on which they act.  
The family of 3-pptases dephosphorylate PI3P, PI3,4P2, PI3,5P2, and PI3,4,5P3 at the 3-
position and are important for regulating growth factor signaling. These enzymes can be found in 
the nucleus, Golgi, ER, and the plasma membrane (Table 1.1). Phosphatase and tensin 
homologue (PTEN) is a ubiquitously expressed 3-pptase that is a known tumor suppressor. 
PTEN dephosphorylates PI3,4,5P3 (PIP3) generating PIP2 which halts PI3K signaling. Loss of 
PTEN leads to increased PIP3 at the plasma membrane and sustained activation of a signaling 
kinase, Akt/PKB. Akt/PKB can influence a number of signaling pathways leading to cell growth 
and proliferation, so sustained activation ultimately causes protection from apoptosis (60).  
Inositol polyphosphate 4-pptases are categorized into types I and II which share 37% 
sequence identity (61). The type I enzymes have been shown to participate in cell growth 
regulation by converting PI3,4P2 to PI3P in the endosomal system (62). Recently, Ungewickell et 
al. identified and characterized type I and II 4-pptases that act on PIP2, are ubiquitously 
expressed, and localize to endosomes and lysosomes (63). Overexpression of either enzyme 
increased epidermal growth factor-(EGF)-receptor degradation following EGF stimulation. 
Additionally, Zou et al. recently found a role for the type I PIP2 4-pptase in stimulating p53-
dependent apoptosis in cells following DNA damage (64).  
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 The inositol polyphosphate 5-pptase (Inpp5p) family is well described and includes 10 
members (Figure 1.5) (65). These enzymes dephosphorylate PIP2 at the 5’ position of the inositol 
ring to produce PI4P. They contain a central catalytic domain flanked by various protein-protein 
interaction domains (66). Below I discuss three of these enzymes and their roles in membrane 
traffic. 
 Synaptojanin is the prototypical Inpp5p involved in clathrin-mediated endocytosis. There 
are two isoforms of this enzyme: synaptojanin 1, which is primarily expressed in neuronal tissue, 
and synaptojanin 2, which is ubiquitously expressed (67). Synaptojanin 1 functions at nerve 
terminals and participates in synaptic vesicle endocytosis. At the synapse, PIP2 helps recruit the 
clathrin adaptor AP-2, and other accessory proteins resulting in the formation and budding of 
clathrin coated vesicles. After endocytosis, synaptojanin 1 dephosphorylates PIP2 causing 
clathrin to dissociate from vesicles (67).  
 Inpp5b is a PIP2 5-pptase with a central 5-phosphatase domain and a carboxy-terminal 
Rho GTPase-activating protein (GAP)-like domain (44). The functional significance of the 
RhoGAP domain is unknown as it lacks a critical catalytic residue GAP activity (68).  PIP2 is the 
preferred substrate for Inpp5b, but it also displays some activity toward PIP3, inositol (1,4,5) 
trisphosphate (IP)3 and I(1,3,4,5) tetrakisphosphate (IP)4  (44). Inpp5b localizes to both the ER-
to-Golgi intermediate compartment (ERGIC) and endosomes through interaction with various 
RabGTPases (69). A knockout mouse model of Inpp5b only exhibited male sterility, revealing 
little about its functions (70). However, consistent with its localization to the early secretory 
pathway, a group has recently reported a role for Inpp5b in membrane traffic at the ERGIC (70).  
 OCRL is the protein encoded by the OCRL1 gene that is mutated or absent in Lowe 
syndrome, a rare X-linked disorder (to be discussed in Chapter 1.5.1). OCRL is highly 
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homologous to Inpp5b, with which it shares 45% amino acid sequence identity, a similar domain 
organization, and substrate specificity. There are two splice variants of OCRL: the longer 
isoform OCRLa is ubiquitously expressed albeit at lower levels than the shorter form OCRLb. 
OCRLb is expressed in all tissues except brain, where OCRLa is most abundant (71). OCRL is 
localized to the TGN, cytoplasmic CCVs, endosomes, and to clathrin coated pits (CCPs) (72-76). 
Localization to the Golgi and endosomes is dependent upon OCRL binding to Rabs, while its 
presence at CCPs is due to the a conserved C-terminal clathrin binding motif (44;77). OCRL 
binds to Rac1 through its RhoGAP domain and translocates to the plasma membrane upon 
growth factor activation of Rac1 (78;79). OCRL’s activity as a PIP2 5- pptase and its localization 
led to the suggestion that OCRL participates in clathrin-mediated trafficking at the TGN and 
endosome interface. Indeed, Choudhury et al. demonstrated that expression of a pptase domain-
deficient version of OCRL inhibited the trafficking of Shiga toxin from endosomes to the TGN. 
Moreover, siRNA-mediated silencing OCRL caused a partial redistribution of the cation-
independent mannose 6-phosphate receptor (CI-MPR) from the TGN to endosomes (75). Given 
its intracellular distribution, it is possible that OCRL may also regulate biosynthetic traffic at 
either the TGN on endosomes, but this possibility has not been tested (5;80). In chapter 2, I use 
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Each of the 10 mammalian 5-pptases are drawn to indicate their overall domain 
organization. All of the enzymes contain a central catalytic domain. The legend 
reveals the identity of each domain by color, the white areas represents 
segments without characterized domains. Inpp5b is listed in this figure as 5-
phosphatase II. Proline-rich inositol polyphosphatase 5-phosphatase (PIPP) and 
SKIP (a skeletal muscle and kidney enriched inositol polyphosphate 5-
phosphatase) contain a unique C-terminal SKICH domain that is important for 
their membrane localization. Synaptojanin 1/2 contain an extra N-terminal 
catalytic domain (Sac-1) that has very broad specificity toward PI3P, PI4P and 
PI(3,5P)2. SHIP2  contain s a sterile α motif (SAM) wh ich  is a p ro tein  
interaction motif, along with SH2 domains and praline-rich domains. Inpp5b 
and OCRL both contain C-terminal RhoGAP-like domains, whose true 
function is unknown as they lack a critical residue for GAP activity. This 
figure was modified from Astle et al. 2007, full reference in text.  
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1.4 PHOSPHATIDYLINOSITOLS AND THEIR FUNCTIONS 
1.4.1 Phosphatidylinositols and Signaling 
Synthesis and degradation of PIPs plays an important role in signal transduction from the plasma 
membrane and can influence the temporal characteristics of a signal or the type of signaling 
cascade. Cleavage of PIP by phosphatases can terminate a signal. Alternatively, ligand binding to 
a G-protein coupled receptor (GPCR) can result in activation of PLC and the formation of the 
second messengers IP3 and DAG (81). IP3 can  diffuse throughout the cytosol until it encounters 
an IP3 receptor leading to rapid release of calcium from intracellular stores such as the ER (82). 
Signaling pathways that increase cytosolic calcium are tightly regulated and cells are quick to 
restore calcium levels to their normal steady state (83). Released calcium binds to and modulates 
the activities of many cellular proteins making it a potent signaling molecule. Membrane-
embedded DAG activates PKC which phosphorylates many cellular targets influencing 
proliferation, differentiation, and survival through pathways such as MAP kinase and nuclear 
factor (NF) ĸ B. Mo reover, DAG has also been shown to participate in cell signaling via non-
PKC-dependent DAG receptors (84).  
Alternatively, phosphorylation of PIP2 to generate PIP3 can terminate PIP2 signaling and 
give rise to growth factor-like signaling via the PI3K/Akt pathway. In general, response to 
growth factors leads to activation of receptor tyrosine kinases (RTKs) and increased PIP3 
production. The formation of PIP3 recruits the ser/thr kinase Akt/PKB to the plasma membrane 
where it is subsequently phosphorylated by mammalian target of Rapamycin (mTOR) and 
phosphoinositide-dependent kinase 1 (PDK1) (85). Once activated, Akt can affect numerous 
cellular targets to induce downstream effects on growth and metabolism. 
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1.4.2 Phosphatidylinositols in Membrane Traffic 
PIPs can influence membrane traffic by recruiting proteins to the inner leaflet of cell membranes, 
affecting membrane curvature and modulating the actin cytoskeleton. These three mechanisms 
aid in vesicle formation or propulsion driving exocytosis, endocytosis, and biosynthetic 
transport. The ability of the cell to compartmentalize PIPs translates into highly regulated 
recruitment of effector proteins to a particular site. This specificity combined with the tightly 
controlled synthesis and degradation of PIPs allows for spatio-temporal regulation of PIP-
mediated processes. In the next three sections, I discuss various domains that enable proteins to 
bind selectively to PIPs at specific intracellular sites, and the role of these domains in membrane 
traffic and in the modulation of actin cytoskeletal dynamics.  
1.4.2.1 Phosphatidylinositol Binding Domains 
The ability of proteins to transiently associate with the cytosolic aspect of membranes is 
important for many cellular processes including signaling, maintaining cell structure, and 
membrane trafficking (86). Much of this binding is mediated by interaction to PIPs through 
diverse mechanisms including sensing of acidic phospholipids, basic motifs, or conserved PIP-
specific binding domains. There are 10 distinct PIP binding domains that fall into two different 
groups based on their overall specificity (86). Generally, lower specificity domains can impart 
temporal characteristics to recruitment, but lack the spatial control of the more highly specific 
domains. The higher specificity binding domains have been successfully used as probes to study 
the steady state localization of individual PIP species within cells (87;88). Below I briefly 
discuss some of the major PI-binding domains including their general structures and affinities for 
PIPs.  
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The Fab1, YOTB, Vac1, EEA1 (FYVE) domain is a 60-70 amino acid zinc finger 
domain that contains a conserved basic motif that allows it to interact with PI3P (89-91). FYVE 
domain-containing proteins bind specifically to PI3P, which is primarily found in the endosomal 
system (89). A prototypical FYVE domain-containing protein is early endosome antigen 1 
(EEA1), which is important for endosome fusion. Dimerization of FYVE domain-containing 
proteins through a coiled-coil domains has been shown to increase the efficiency of PI3P-binding 
(92;93).  
The phox (PX) domain was first identified as a part of the NADPH oxidase complex and 
was later determined to bind to PI3P (94;95). PX domains are approximately 130 amino acids in 
length and in addition to binding PI3P they also bind to PI3,4P2 or PIP2 (96;97). PX domains are 
found in all sorting nexins (SNX), a diverse group of proteins important for several membrane 
trafficking steps (98). These domains also require some degree of dimerization or interaction 
with an oligomeric complex to increase their efficiency for PI3P binding (99;100).   
 Pleckstrin homology (PH) domains are approximately 100 amino acid motifs originally 
described in the protein pleckstrin, and were shown to bind phosphoinositides (101). The PH 
domain of phospholipase Cδ1 (PLCδ) was demonstrated to bind specifically to PIP2 and has been 
used as a probe to study PIP2  (102;103). The crystal structure of the PLCδ-PH reveals seven β-
strands and one α-helix and a deep pocket containing charged residues that are important for PIP2 
binding (104).  
A key mechanism by which PIPs act as markers of organelle identity or to recruit 
proteins is via coincidence detection. The principle behind coincidence detection is that low 
affinity interactions of a protein with PIPs can be enhanced by binding to a second signal, and 
that this dual interaction increases the strength and specificity of the interaction. The second 
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signal can be another lipid, a protein, or a curved membrane domain (105). For example, the 
recruitment of FAPPs to the Golgi complex requires binding to both PI4P and the small GTPase 
Arf1 (106). Also, SNXs use coincidence detection to recognize PI3P via a PX domain and highly 
curved endosomal tubules through their Bin/Amphiphysin/Rvs domain (107). Coincidence 
detection, through combination of signals, increases the number of ways PIPs can be engaged by 
cytoplasmic proteins to ensure spatial control over cellular processes. 
1.4.2.2 Phosphatidylinositols in Exocytosis and Endocytosis 
The formation of vesicles during endocytosis and the fusion of two membranes during 
exocytosis rely on a significant contribution by the phospholipids in both membranes. 
Phosphatidylinositols, particularly PIP2, have been demonstrated to be important in both 
pathways to regulate recruitment of adaptor proteins and to serve as a biochemical marker of 
membrane identity.  
The events leading up to exocytosis are tethering, docking, priming, and fusion (108). 
The overall goal is to bring the two membranes within close proximity of each other so that the 
vesicle may either fuse or partially fuse to release its contents. The core machinery responsible 
for the fusion event is the soluble N-ethylmaleimide-sensitive factor attachment protein receptor 
(SNARE) proteins. Once a vesicle is tethered, v-SNARES and t-SNARES interact to bring the 
vesicle into close proximity with the membrane (109). Increases in Ca2+ are sensed by 
synaptotagmin which is thought to induce final fusion of the complex by helping to overcome 
the energy barrier of fusion (110). Synaptotagmin has a single transmembrane domain and it 
interacts with PIP2 in a Ca2+-dependent fashion to stimulate vesicle fusion in conjunction with 
increases in Ca2+ (36;111;112). PIP2 may also play a role in marking the plasma membrane as a 
site for fusion and in cooperating with t- and v-SNARE pairing (36;109). Consistent with this, 
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PIP2 forms clusters on the plasma membrane near areas of high syntaxin-(t-SNARE) density that 
contain docked vesicles. Increases in PIP2 show a positive correlation with the number of 
syntaxin clusters and the magnitude of the Ca2+-dependent exocytic response (113-116). In 
polarized epithelial cells, fusion of vesicles with the basolateral surface may be mediated by 
interactions with the exocyst, a known tethering complex, which has been shown to interact with 
PIP2 (117).  
PIP2 also acts as a recruitment factor for endocytic proteins, and is important for all forms 
of endocytosis (36). All of the AP complexes and other clathrin adaptors, such as AP180 and 
epsin, bind to PIP2 at the plasma membrane (67;118;119). Assembly of CCVs requires the 
coordinated action of protein-lipid and protein-protein interactions. Briefly, PIP2 at the plasma 
membrane can recruit the AP-2 complex, which interacts with cargo containing tyrosine- or 
dileucine-based endocytic signals. Subsequently, clathrin triskelia assemble onto the AP-2-cargo 
complex to form a clathrin lattice (120). This assembly is partially responsible for the 
invagination of the membrane. The vesicle is ultimately severed from the membrane by the PIP2-
interacting GTPase, dynamin (121;122). In addition to these classical players in clathrin-
mediated endocytosis, an additional family of adaptors termed clathrin-associated sorting 
proteins (CLASPs) bind to PIP2, APs, and to other cargo endocytic signals, thus increasing the 
range of cargo recruited to coated pits (123). The actin cytoskeleton is also important for 
efficient CCV endocytosis (124). A potent stimulator of actin polymerization, neuronal Wiskott-
Aldrich syndrome protein (N-WASP) is recruited by PIP2 and is thought to help provide the 
force to propel detached CCVs into the cytosol (125). Once endocytosis occurs, pptases such as 
synaptojanin quickly dephosphorylate PIP2 to PI4P allowing the coat components to dissociate 
so they may be recycled for another round of endocytosis (126). Increases in PIP2 at the plasma 
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membrane have been suggested as a mechanism to modulate the rate/efficiency of clathrin 
mediated endocytosis presumably by increasing recruitment of proteins that mediate/regulate 
endocytosis.  This phenomenon has been observed in nonpolarized cells in which overexpression 
of PI5Ks stimulates the rate of Tfn receptor endocytosis and in IgA endocytosis polarized 
epithelial cells (59;127). 
1.4.2.3 Phosphatidylinositols in Biosynthetic Membrane Traffic 
PIPs are important for the recruitment of cytoplasmic machinery for cargo selection, vesicle 
formation, and the movement of proteins though the biosynthetic pathway (128;129). Consistent 
with this, exit from the ER is dependent on COP II, which consists of Sec 23/24, Sec 13/31, and 
the small GTPase Sar1. In studies using liposomes, the recruitment of Sec 23/24 was shown to 
depend on acidic phospholipids, such as phosphatidic acid (PA) and PIP2. Phospholipase D 
(PLD) activity has also been shown to be important for ER exit (130). PLD cleaves an abundant 
membrane constituent, phosphatidylcholine (PC) into PA, a known cofactor/activator of many 
PIP kinases (131). Recently, Blumental-Perry et al. showed that PI4P is locally concentrated at 
ER exit sites. Sar1 was shown to transiently stimulate PI4P and PIP2 formation on ER 
membranes. By expressing PIP-binding domains to sequester PIPs, they demonstrated that both 
PI4P and PIP2 were necessary for efficient ER export (132). Together these studies highlight the 
importance of PIPs in the binding of coat proteins to the ER and the formation of ER vesicles.  
The Golgi complex contains the majority of cellular PI4P. As described earlier, PI4P in 
the Golgi is generated by the action of PI4Ks. Weixel et al. demonstrated that two different 
PI4Ks, PI4KIIα and PI4KIIIβ localize to different subdomains of the Golgi and can regulate 
distinct pools of PI4P (49). One mechanism by which PIPs may affect the Golgi is through 
alterations in membrane curvature. The flattened cisternae of the Golgi have highly curved 
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surfaces at the ends of each stack, which may rely on PI4P to maintain their structure and/or 
stimulate vesicle budding from these sites. In support of this, studies using the expression of 
catalytically-inactive forms of PI4Ks or siRNA knockdown have  revealed that PI4P is important 
for Golgi structure and biosynthetic traffic from the TGN  (50;133;134). In addition, Golgi 
reformation is markedly delayed in cells expressing a dominant-negative PI4K, indicating a 
possible requirement for PI4P in Golgi biogenesis.  
In addition to direct effects on membrane curvature PI4P may influence the Golgi 
through the recruitment of effectors. Indeed, several effector proteins bind to PI4P in the Golgi 
including epsinR, AP-1, four-phosphatase-adaptor proteins (FAPPs), and oxysterol binding 
protein (OSBP) (106;133;135;136). Synthesis of PI4P at the Golgi may be important for 
continued recruitment of effectors in a positive feedback loop that modulates Golgi function. In 
support of this, FAPP binds to PI4P and ADP-ribosylation factor 1 (Arf1) at Golgi exit sites. 
Knockdown or displacement of FAPPs with a competing PH domain disrupts Golgi to plasma 
membrane transport (106). The small GTPase Arf1 is important for vesicle budding because it 
recruits numerous effectors and PI4KIIIβ to Golgi membranes (137;138). Arf1 is also 
responsible for recruiting coat complexes to the Golgi, including the aforementioned AP-1, COP 
I for retrograde transport, and the Golgi-associated, γ-adaptin ear-containing, Arf binding (GGA) 
proteins for Golgi-to-endosome transport (139). These data represent a pathway of Arf activation 
leading to increased PI4P synthesis that allows the recruitment of factors such as FAPPs to 
influence membrane traffic. 
A positive feedback loop involving Arf1 has also been proposed to influence PIP2 in the 
Golgi. Arf1 can stimulate the activity of PLD, resulting in increased cleavage of PC to PA, 
which is a cofactor/activator of PI5K. PI5K could increase Golgi PIP2 by utilizing PI4P as a 
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substrate. PIP2 has also been shown to stimulate Arf activity which would in theory lead to a 
positive feedback loop for increasing PIP2 at the Golgi (58). While there is no direct evidence for 
the existence of this pathway, the circumstantial evidence is strong. Arf1 can also recruit PI5K to 
Golgi membranes to generate PIP2 (42). Although no PI5K isoform has been localized to the 
Golgi, the presence of OCRL in the TGN makes a strong case for regulated PIP2 metabolism in 
the Golgi. Several studies have alluded to the possible roles of PIP2 in biosynthetic traffic at the 
Golgi, but these have not been directly tested. It is possible that PIP2 could help regulate Golgi 
traffic by recruiting coat complexes, specific sorting receptors, or proteins that can modulate 
actin cytoskeletal dynamics. In chapter 3, I explore the role of PIP2 and actin in biosynthetic 
traffic by modulating PIP2 levels or the activity of the PIP2-dependent stimulator of actin 
polymerization N-WASP. 
1.4.2.4 PIP-mediated Modulation of Actin 
Actin plays an important role in many cellular processes including maintenance of cell shape, 
cell motility, and vesicular traffic. Actin is a small globular protein (~42 kDa) that is highly 
conserved throughout higher and lower eukaryotes.  In its monomeric form actin is referred to as 
globular or G-actin. Actin monomers have a binding site for ATP and they will dimerize upon 
ATP binding to create a “nucleation site” for the polymerization of additional actin monomers, 
which assemble into an actin filament (F-actin) with increasing efficiency. Growth of the actin 
filament occurs at what is termed the barbed end (plus end), while depolymerization occurs as 
the slower growing pointed end (minus end). A number of actin accessory proteins exist to 
modify actin filaments by crosslinking, capping, or severing actin filaments. Actin 
polymerization can be regulated by GTPases, nucleation promoting factors (NPFs), or by PIPs 
(140-142).   
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PIPs can modulate actin polymerization through recruitment of proteins that directly bind 
to actin. For example, the recruitment and activation of N-WASP by PIP2 influences vesicle 
movement via actin-mediated propulsion. N-WASP is a ubiquitously expressed neuronally-
enriched member of the Wiskott-Aldrich syndrome protein (WASP)/WASP family verprolin 
homologues (WAVE) family of proteins. Wiskott-Aldrich syndrome (WAS) is a rare X-linked 
disorder caused by mutations in the gene for WASP and symptoms include bloody diarrhea, 
eczema, and greater susceptibility to infections (143;144). WASP is only expressed in 
hematopoietic cells and WAS fits into a group of cytoskeletal diseases including hereditary 
spherocytosis, hereditary elliptocytosis, and Duchenne muscular dystrophy because WASP is 
part of a cytoskeletal complex (145). A known peculiarity of these diseases is the presence of 
surface proteins with abnormal glycosylation or deficiencies in surface glycoproteins, 
implicating the requirement for a normal cytoskeleton in order to properly traffic proteins to the 
cell surface (145). Since N-WASP is ubiquitously expressed it may have roles in protein 
trafficking in all cell types. Below I discuss the functions of N-WASP-Arp2/3 complex and how 
it is regulated by PIP2 and accessory proteins. 
1.4.2.5 N-WASP Function in Membrane Traffic 
N-WASP participates in cellular functions from cell motility to vesicular traffic. The N-WASP-
knockout mouse embryo survives past gastrulation, but severe developmental delays are evident 
followed by death on or before embryonic day 12 (146). This highlights the importance of N-
WASP in development, maintenance of cell shape, and organ integrity.  
N-WASP is well known for its role in the actin-based motility of pathogens such as 
Shigella flexneri, but it is also important for the movement of organelles and vesicles. Some 
bacteria and virus have evolved mechanisms to highjack the cellular machinery controlling actin 
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polymerization in order to enhance their spread (147;148). S. flexneri possesses a protein, VirG, 
that recruits host cell N-WASP to the tip of the bacterium allowing it to exhibit actin-based 
motility (149). By contrast, Listeria monocytogenes uses a protein, ActA, that mimics the 
function of N-WASP giving it the capability to rocket around the host cell and into adjacent cells 
(150). In either case, rocketing is mediated by the localized and highly efficient formation of 
branched actin filaments at the surface of the pathogen. It is apparent that N-WASP is important 
for the movement of intracellular bacteria, but at the time of these studies its role in vesicular 
traffic was not clear. 
N-WASP participates in endocytic traffic by interacting with endocytic complexes and 
helping to promote vesicle scission. N-WASP was first identified by Miki et al. in 1996 as an 
actin-depolymerizing protein that transiently associates with activated epidermal growth factor 
(EGF) receptor (151). The first link between N-WASP and endocytic traffic came from the 
discovery of an interaction between N-WASP and syntaptic dynamin-associated protein I 
(syndapin I). Syndapin I interacts with dynamin I, synaptojanin, and N-WASP providing 
evidence that N-WASP may influence endocytosis (152). Direct evidence demonstrating that N-
WASP is involved in endocytosis was observed in 2002. Kessels et al. disrupted N-WASP 
function or localization and found a profound negative effect on receptor-mediated endocytosis 
(153). It was later shown that N-WASP is recruited to CCVs during the late stages of vesicle 
formation and disrupting recruitment causes an accumulation of CCVs at the plasma membrane 
(154;155). Together, these data indicate that N-WASP is recruited to the site of clathrin-
mediated endocytosis and is important for mediating vesicle scission or movement away from 
the membrane.  
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N-WASP has also been proposed to function in vesicle propulsion at the Golgi. In 1999, 
a group studying vaccinia virus actin-based motility found that “little actin tails” (LATs) were 
associated with clathrin, but not with an endocytic protein (transferrin receptor) (156). They 
interpreted their data to mean that these structures originated from the Golgi complex. 
Interestingly, the outer membrane of vaccinia virus derives from TGN membrane during the 
enveloping process (157). Vaccinia has since been shown to recruit N-WASP, which is 
responsible for its actin-based motility (146). In 2000, Rozelle et al. showed that actin comets 
whose formation was stimulated by PI5K overexpression were enriched in proteins that associate 
with lipid-rafts. They examined the number of comets associated with HA or VSV-G at time 
points between 2 and 6 hours post-infection and found comets to be more enriched in HA than 
VSV-G (158). While these data support a role for N-WASP comets in biosynthetic traffic, it 
cannot be determined from their studies whether actin comets affect the kinetics or some other 
aspects of the transport of these proteins. Therefore, prior to my research, the actual contribution 
of N-WASP in vesicular traffic from the Golgi remains unclear. In chapter 2, I explore the role 
of N-WASP in TGN-to-plasma membrane delivery of raft- and non-raft-associated proteins by 


























The various domains of N-WASP, WASP and WAVE are indicated 
starting with the highly conserved N-terminal WASP homology 
domain (WHD) which is highly conserved and is important for 
interaction with WASP-interacting proteins (WIPs). The B motif is a 
highly basic region that mediates interaction with PIP2. WASP and 
N-WASP contain a GTPase binding domain (GBD) causing them to 
interact with GTPases like Cdc42. The poly-proline (P) domain of 
each is important for protein-protein interactions. The verprolin 
homology (V) domain, which binds to actin monomers, the cofilin 
homology (C), and the central acidic (A) domain, which binds to 
Arp2/3, collectively make up the highly conserved functional WA 
domain. This figure was adapted from Stradal et al. 2004, full 
reference in text.  
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N-WASP assumes an autoinhibitory conformation and remains inactive 
in the cytoplasm. Following PIP2 synthesis, N-WASP is recruited to the 
membrane through an interaction between the B motif and PIP2. Cdc42 
can bind to the GBD domain to help activate N-WASP, which can then 
recruit Arp2/3 leading to branched actin filament formation or actin 
comet formation. Wiskostatin (wisk) can stabilize the autoinhibitory 
conformation locking N-WASP in an inactive state or the WA domain 
can be used to inhibit the association of Arp2/3 with N-WASP. Figure 
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1.4.2.6 N-WASP-Arp2/3 and its Regulation 
N-WASP is regulated in a number of ways to ensure exquisite spatial and temporal control of N-
WASP-dependent functions. The V,C, and A domains are collectively termed the VCA region 
(WA domain), where the V (W) domain interacts with actin monomers and the CA (A) domain 
interact with the Arp2/3 complex (159-162) (Figure 1.6). The Arp2/3 complex binds to an 
existing actin filament and uses itself as a nucleation site for the polymerization of a new actin 
filament at a 70º angle to the existing actin filament (163;164). N-WASP is normally folded in an 
autoinhibitory conformation in which the WA domain binds to the GBD domain. This interaction 
prevents the recruitment of the Arp2/3 complex to N-WASP, thereby inhibiting actin 
polymerization (165). Autoinhibition is relieved through dual activation of N-WASP by Cdc42 
and PIP2  (160;161;165-167). The lysine-rich B motif of N-WASP binds to PIP2, while GTP-
bound Cdc42 binds to the GBD, inducing a change in conformation leading to N-WASP 
activation at the target membrane (168;169). It has also been shown that increases in local PIP2 
concentration can  recruit, unfold, and activate N-WASP even in the absence of Cdc42 
(158;170). N-WASP binds numerous SH3 domain-containing proteins through its proline-rich 
region allowing it to be recruited to specific sites (171-173). Phosphorylation of N-WASP’s 
GDB domain by Src-family tyrosine kinases plays an important role in N-WASP’s sustained 
activation presumably by relieving autoinhibition (174-176). To support this, mutations in key 
N-WASP tyrosine residues that mimic phosphorylation result in constitutive activation of N-
WASP (168). 
 Several approaches have been used to inhibit N-WASP function. The WA domain of N-
WASP or other WAVE family proteins has been used as a dominant negative construct for N-
WASP (158;161). When used for in vitro actin polymerization experiments, the WA domain acts 
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as a constitutively active construct because it not autoinhibited like full-length N-WASP (177). 
However, in vivo the WA domain binds to and sequesters Arp2/3 from N-WASP thereby 
inhibiting actin polymerization downstream of N-WASP (Figure 1.7) (169). Use of the WA 
domain lacks complete specificity as this domain is highly conserved among the WASP/WAVE 
family; therefore, this construct could also inhibit Arp2/3-mediated actin polymerization 
downstream of other NPFs such as WAVEs. A more selective way to inhibit N-WASP was 
described in 2003 by Peterson et al., who conducted a screen for compounds that inhibit PIP2-
stimulated actin polymerization in vitro. The study identified wiskostatin as a small molecule 
inhibitor that binds to and stabilizes the autoinhibitory conformation of N-WASP (wisk; Figure 
1.7). Using assays that measure the rate and extent of actin polymerization the group showed that 
wiskostatin potently inhibits N-WASP activity in vitro (178). In addition to this approach, some 
groups have also used either siRNA or a knockout mouse to study the role of N-WASP in 
various cellular processes. In chapter 3, I explore the role of N-WASP in polarized biosynthetic 
traffic using expression of the WA domain, wiskostatin, and siRNA-mediated knockdown to 
disrupt N-WASP function. 
1.5 PHOSPHATIDYLINOSITOL METABOLISM AND DISEASE 
Given the multiple roles of PIPs in cell homeostasis it is not surprising to find diseases resulting 
from aberrant PIP metabolism. Loss of proper PIP metabolism and signaling has been linked to 
diseases such as cancer, Type 2 diabetes, Down syndrome, and Lowe syndrome (179). The 
fundamental differences between these diseases reinforce the diversity of cellular functions that 
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rely on efficient PIP metabolism. In the following sections, I briefly discuss the faulty pathway 
that leads to each disease.  
PI3K/PTEN-regulated PIP3 metabolism is involved in cell proliferation, apoptosis, 
metabolism, signaling, and cell growth (180). The gene for PTEN was first identified as a tumor 
suppressor located in an area of chromosome 10 associated with breast and prostate cancer 
(181;182). The ability of PTEN to suppress tumors was later found to be the result of its ability 
to dephosphorylate PIP3 (183;184). Mutations in PTEN cause the inherited diseases Cowden 
disease and Bannayan-Zonana syndrome, which are characterized by multiple hamartomas 
(benign growths) but also an increased risk of malignant tumors (179). Mutations that increase 
PI3K activity have also been linked to certain cancers, such as colorectal cancer and 
glioblastomas (85). 
Type 2 diabetes results from a decreased or loss of response to insulin leading to 
hyperglycemia. A number of proteins normally act as modifiers of this pathway by suppressing 
downstream signaling from the insulin receptor, including the PIP3 5-pptase Src homology 2-
containing inositol-5-phosphatase (SHIP2) (179). Insulin signaling is mediated through the 
PI3K/Akt pathway, and SHIP2 activity suppresses insulin signals by decreasing the available 
PIP3. In a study that compared 4 control subjects and 8 patients with type 2 diabetes, it was found 
that one disease patient was lacking a 16 bp region of the SHIP2 3’ untranslated region. Deletion 
of this region increases SHIP2 expression thereby dampening insulin signaling resulting in type 
2 diabetes (185;186).  
Symptoms of complex multi-gene disorders, such as Down syndrome, have been 
attributed to problems with PIP2 metabolism. Down syndrome is caused by chromosome 21 
trisomy, and therefore patients have an extra copy of chromosome 21 genes, including 
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synaptojanin 1 (synj1). Researchers discovered that the Down syndrome model mouse has a 
defect in PIP2 homeostasis. As discussed earlier, regulation of PIP2 metabolism is important for 
synaptic vesicle cycling, therefore dysregulation of PIP2 may be responsible for altered cognitive 
function in Down patients. Furthermore, altered PIP2 metabolism is recapitulated in transgenic 
mice designed to contain an extra copy of Synj1 causing the mice to have a deficit in completing 
cognitive tasks (187).     
1.5.1 Lowe Syndrome 
Lowe syndrome results from mutations in the gene OCRL1. Lowe syndrome is a rare X-linked 
disorder characterized by mental retardation, congenital cataracts, poor muscle tone, and renal 
Fanconi syndrome (low molecular weight proteinuria (lmwp), hypercalciuria, and 
nephrocalcinosis) (44;188). The cause of the pathologies of Lowe syndrome are not known, but 
it is hypothesized that they may be due to defects in membrane traffic. OCRL is a 105kDa PIP2 
5-pptase that was originally localized to lysosomes, but has since been found primarily in the 
TGN, endosomes, and CCPs (73;75;76). The localization of OCRL is not coincident with the 
major pool of PIP2 in the plasma membrane. Therefore, OCRL may function to regulate a small 
pool of PIP2 that is generated and important at intracellular sites. 
  OCRL shares a similar phenotype with another X-linked disorder, Dent disease, which 
arises from mutations in the chloride-proton antiporter, ClC-5, and ultimately results in renal 
Fanconi syndrome (lmwp, glycosuria, aminoaciduria, and phosphaturia) (189;190). While Dent 
disease is predominantly caused by ClC-5 mutations, some Dent patients were found to have 
mutations in OCRL. These patients exhibited lmwp, but not the other main clinical phenotypes 
of Lowe syndrome (189;191). A detailed study comparing the kidney phenotype of Dent patients 
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and Lowe patients revealed that Lowe syndrome seems to result in a selective proximal tubule 
dysfunction, and lack the glycosuria found in Dent disease (192). Of note, are mutations OCRL 
that cause Dent disease are often found on or before exon 7 of the OCRL gene. However, this 
finding provides little insight into the mild Lowe phenotype of these patients as the mutations 
frequently result in complete loss of protein expression (189;193). The similarities in the reneal 
symptoms between the Dent disease and Lowe syndrome suggest that they share a common 
mechanism underlying their pathophysiology. Fanconi syndrome in Dent disease is thought to be 
caused by a loss of function of the multi-ligand scavenger receptor megalin, which reabsorbs 
proteins and other ligands in the kidney proximal tubule (194). It has been hypothesized that the 
Fanconi syndrome phenotype in Lowe syndrome is similarly caused by aberrant megalin 
trafficking, but this has not been examined directly. 
 Megalin is a member of the LDL-receptor family that is trafficked through the secretory 
pathway in association with its chaperone receptor associated protein (RAP), which prevents 
premature ligand binding to the receptor. At the cell surface megalin associates and traffics with 
a co-receptor cubilin. Together, megalin and cubilin internalize over 20 different ligands from 
the kidney filtrate. Once the ligand has been internalized and dissociates from the receptor, 
megalin then recycles to the cell surface (195). Interestingly, Lowe syndrome patients have been 
shown to shed less megalin in their urine, also a feature of Dent disease. Megalin normally 
undergoes regulated intramembranous proteolysis at a low basal rate, therefore less megalin in 
the urine suggests that less of the receptor is present at the apical surface at steady state 
(196;197). Since OCRL has been localized to both endosomes and the TGN, it is reasonable to 
hypothesize that OCRL activity may influence membrane traffic of megalin along either the 
biosynthetic or the endocytic/recycling routes (75). Indeed, OCRL has been shown to play a role 
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in endosome-to-TGN traffic of CI-MPR, but whether OCRL is involved in membrane traffic 
along the biosynthetic pathway remains to be tested. 
1.6 GOALS OF THIS DISSERATION 
For my dissertation I investigated the role of PIP metabolism in biosynthetic traffic. In polarized 
epithelial cells, biosynthetic transport of proteins is directed by sorting at either the TGN or 
endosomes that ensures proteins are sent to the correct membrane domain. Some information is 
available about the mechanisms that regulate basolateral sorting, however those that govern the 
sorting of distinct classes of apical proteins have not been thoroughly investigated. Lipids, 
including phosphatidylinositols, play important roles in vesicular traffic. PI4P is highly enriched 
in the Golgi complex and influences membrane traffic through that organelle. PI4P may also 
serve as a substrate for synthesis of PIP2 in the Golgi. The role of PIP2 metabolism in polarized 
biosynthetic traffic is not well known but could involve PIP2 effector proteins, such as N-WASP 
to engage the actin cytoskeleton. In addition, while actin is known to be important for membrane 
traffic, the involvement of N-WASP in biosynthetic traffic has been largely unexplored. 
To explore the role of phosphatidylinositol metabolism in polarized biosynthetic traffic, I 
have studied the effect of overexpression or knockdown of PIP2-metabolizing enzymes on 
biosynthetic traffic of apical and basolateral proteins. The first goal of this study was to 
determine if there is a role for PIP2-metabolism in biosynthetic traffic and to characterize 
proteins that are sensitive to PIP2 levels based on their sorting signal. The second goal of my 
work was to determine if actin polymerization via N-WASP/Arp2/3 is important in biosynthetic 
  40 
traffic. These studies fill an important gap within the literature and have the potential to 
contribute to therapeutic treatments for Lowe syndrome.  
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2.0     THE ROLE OF PHOSPHATIDYLINOSITOL METABOLISM IN POLARIZED 
BIOSYNTHETIC TRAFFIC 
2.1 INTRODUCTION 
The maintenance of polarized cell function requires continuous active sorting and delivery of 
newly synthesized proteins and lipids to differentiated apical and basolateral plasma membrane 
domains. Tight junctions between the cells prevent the diffusion of surface proteins between 
these domains, but polarity is established and maintained largely by the selective delivery and 
recycling of proteins to their appropriate site of function. In polarized renal cells, it is thought 
that newly synthesized proteins are sorted initially at the trans-Golgi network (TGN) into distinct 
carriers destined for the apical or basolateral domain  (29;198). Transport of some proteins to 
their ultimate destination may be indirect and include passage through endosomal compartments 
or the opposite surface domain (198).  
The sorting of individual proteins to the apical and basolateral cell surface domains is 
signal-mediated. Basolateral sorting signals generally reside in the cytoplasmically-disposed 
regions of proteins whereas glycan-, lipid-, and peptide-dependent signals have been identified 
that reside in the lumenal, membrane-associated, or cytoplasmic regions of distinct apically-
targeted proteins  (198). Little is known about how the sorting machinery recognizes these 
diverse signals.  A current model suggests that preferential incorporation of a subset of apical 
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proteins, including those with glycosphingolipid anchors or sorting signals within their 
transmembrane domains, into glycolipid-enriched microdomains (lipid rafts) is important for 
their polarized delivery (29). Interestingly, apical delivery of raft vs. non-raft proteins may 
involve distinct transport carriers that are independently regulated (9;199).  
There is increasing evidence for a role of phosphatidylinositols in the regulation of 
biosynthetic membrane traffic (59). The Golgi contains a sizable pool of PI4P and harbors two 
PI4P-synthesizing enzymes (PI4KIIIβ and PI4KIIα) (49;50;134;200). Previously it has been 
demonstrated that overexpression of PI4KIIIβ inhibits the rate of apical membrane delivery of 
the raft-associated protein influenza HA, whereas expression of a kinase-deficient mutant 
stimulates delivery  (50). However, it is conceivable that these effects are due to a downstream 
metabolite of PI4P, such as PIP2. Indeed, although there is only a small amount of this lipid that 
can be visualized in the Golgi complex (43), PIP2 is readily generated on isolated Golgi 
membranes incubated with phosphatidylinositol 4-phosphate 5-kinases [PI5Ks; (42)] and several 
possible functions for PIP2 in biosynthetic membrane traffic have been postulated (59;201;202). 
Additionally, the presence of OCRL, a TGN-localized PIP2 5-pptase that is defective or absent in 
patients with oculocerebrorenal syndrome of Lowe, lends further support to a role for PIP2 
metabolism in that compartment (72;73).  
Lowe syndrome is characterized by mental retardation, congenital cataracts, and renal 
Fanconi syndrome (44;188). While the degree of each phenotype may vary, Lowe Syndrome 
patients universally have renal Fanconi syndrome, which is characterized by defective absorption 
of low molecular weight proteins in the proximal tubule. Protein uptake from the apical surface 
of these cells is dependent on megalin, a recycling receptor that mediates the uptake and ultimate 
degradation of protein ligands (195). Observations made in cells from Lowe syndrome patients 
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reveals that PIP2 levels are slightly increased due to lack of OCRL, consistent with its function as 
a PIP2 5-pptase (203). While a role for OCRL in endosome to TGN traffic has been reported, the 
role of OCRL-regulated PIP2 metabolism in biosynthetic traffic has not been explored (75). Here 
I have examined the effect of increasing PIP2 synthesis on polarized biosynthetic traffic in 
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2.2 RESULTS 
2.2.1 Localization of PI5K and OCRL in MDCK Cells 
The localization of murine PI5KIα (PI5K) and human OCRL was determined via adenoviral 
(AV)-mediated overexpression in MDCK cells, as they are a well established model to study 
trafficking in polarized epithelial cells. Due to the lack of available antibodies that recognize 
endogenous canine PI5K, indirect immunofluorescence was performed to visualize the HA 
epitope tag of overexpressed PI5K. In nonpolarized MDCK cells, PI5K localizes to the plasma 
membrane and also to filamentous structures in the cytoplasm (Figure 2.1 top row). This 
localization is reminiscent of the observed localization of PI5Ks in other adherent cell lines 
(204). However, in polarized MDCK cells, PI5K is highly concentrated in the apical pole of the 
cells and is absent from the basolateral surface (Figure 2.1 middle and bottom panels). By 
contrast, in nonpolarized cells OCRL has a very defined localization to cytoplasmic punctae and 
the juxtanuclear region consistent with its reported localization in endosomes and the TGN 
(Figure 2.1 top row). Prior to this work, the localization of OCRL in polarized epithelial cells 
had not been examined. My data indicate that OCRL is localized to punctae in the periphery of 
the cell and above the nucleus (Figure 2.1 middle and bottom panels). Since the OCRL antibody 
I used only recognized exogenously expressed OCRL, these data must be interpreted cautiously. 
However, the bright OCRL staining above the nucleus and below the tight junctions (not shown) 
is consistent with Golgi localization, while the lateral punctae may be endosomal compartments.  
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MDCK cells were electroporated with a cDNA construct encoding mPI5KIα, or infected 
with AV-OCRL and plated sparsely on coverslips (top row) or plated onto Transwell filters 
for 3 days prior to fixation and processing for immunofluorescence(remaining panels).  HA-
tagged PI5K and OCRL were detected using a monoclonal antibodies and an AlexaFluor 488 
secondary antibody.  Confocal sections were captured using a spinning disc confocal 
deconvolved using Metamporph software show representative PI5K or OCRL staining from 
the apical pole, lateral and basal regions of the cell.  The bottom row shows deconvolved xz 
sections from the filter-grown cells. Scale bars represent ~10μm.  
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2.2.2 PI5K Selectively Stimulates Biosynthetic Delivery on an Apical Raft-associated 
Protein 
I examined the effect of AV-mediated overexpression of PI5K on biosynthetic traffic in 
polarized MDCK cells. Overexpression of PI5K increased cellular levels of PIP2 by 2-fold 
(Figure 2.2) but did not alter intra-Golgi kinetics based on the quantitation of the rate of HA 
acquisition of endoglycosidase H (endo H) resistance (Figure 2.3A). To examine the effects of 
PI5K on post-Golgi transport, I staged newly-synthesized HA in the TGN at 19ºC, and using a 
cell surface trypsinization assay measured the rate of its delivery to the cell surface upon 
warming to 37ºC. Roughly 50% of the total HA expressed in control cells reached the apical 
membrane in 1 h (Figure 2.3B). In contrast, HA delivery was markedly stimulated in cells 
overexpressing PI5K (~67% at 1 h). 
I next examined the effect of PI5K on the TGN-to-surface transport kinetics of p75, an 
apical marker that is not known to associate with lipid rafts in MDCK cells (Figure 2.3 C), as 
well as on the basolateral marker vesicular stomatitis virus G protein (VSV-G) (Figure 2.3D). 
PI5K had no effect on the biosynthetic delivery of either of these proteins. Thus, the stimulatory 



























































Filter-grown MDCK cells were infected with control AV, AV-
PI5K, AV-OCRL or AV-OCRL mutant (mut; R483G).  To 
assay for phospholipids levels, cells were incubated briefly in 
phosphate-free media, labeled for 4 hr with 32P-orthophosphate 
and extracted using chloroform:methanol:HCl.  Extracted lipids 
were separated using thin layer chromatography (TLC).  
Densitometry was used to quantify the intensity of each band 
and relative amounts were determined.  Data for PIP2 were 
normalized to the control PIP2 percentage.  Error bars represent 
mean +/- std error for at least n=4 independent experiments. * 
represents p≤0.004. 
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Figure 2.3 TGN to apical membrane delivery of a raft-associated protein is selectively 


























A, Filter-grown MDCK cells co-infected with AV-HA and either control AV or AV-PI5K were 
starved, radiolabeled for 5 min, and chased at 37ºC for the indicated time periods. HA was 
immunoprecipitated from cell lysates, the samples were treated with endo H, and the fraction of 
HA that was resistant to endo H at each time point was quantitated. Similar results were 
obtained in three experiments. B, MDCK cells co-infected with AV-HA and either control AV, 
AV-PI5K or AV-OCRL were radiolabeled for 15 min and chased for 2 h at 19ºC. Apical 
delivery of HA was quantitated by cell surface trypsinization at various times after warming to 
37ºC. Similar results were obtained in 13 experiments comparing HA transport in control and 
PI5K-expressing cells. C, MDCK cells co-infected with AV-p75 and either control AV or AV-
PI5K were radiolabeled for 2 h at 18oC with [35S]-sulfate prior to warming to 37ºC for the 
indicated times. Apical delivery of p75 was quantitated by domain selective biotinylation. 
Similar results were obtained in three independent experiments. D, MDCK cells co-infected 
with AV-VSV-G and either control AV or AV-PI5K were radiolabeled and then chased for 2 h 
at 19ºC prior to warming to 37ºC for 0 or 60 min. Basolateral delivery was quantitated by 
domain selective biotinylation. The mean +/- S.E.M. of the indicated number of experiments 
performed in triplicate or quadruplicate is plotted;  n=3 for 0’;  n≥4 for 60’. * p≤0.02 vs. control 
at 0’. MDCK cells co-infected with AV-HA (E) or AV-p75 (F) and either control AV or AVs 
expressing wild-type or kinase-deficient OCRL were starved in sulfate-free media for 30 min 
and radiolabeled for 2.5 h at 18ºC with [35S]-sulfate prior to warming to 37ºC. Apical delivery 
of HA (at 1 h) was quantified using cell surface trypsinization; delivery of p75 (at 2 h) was 
quantitated by domain selective biotinylation. The percent delivery (mean +/- S.E.M.) of HA 
(n=3) and p75 (n=5-6) is shown. * denotes statistical significance from control measured using 
Student’s t test (p=0.004) 
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2.2.3 Overexpression of OCRL Selectively Inhibits Biosynthetic Delivery of Influenza HA 
To examine whether stimulation of PIP2 synthesis in the TGN was responsible for the effect of 
PI5K, I compared the effect of overexpressing the TGN-localized PIP2 5-pptase OCRL or 
expressing a phosphatase-deficient mutant of OCRL on the delivery of HA and p75. 
Overexpression of OCRL decreased PIP2 levels by approximately 30% while expression of the 
phosphatase-deficient mutant had no significant effect on PIP2 levels (Figure 2.2). Because 
overexpression of both wild type and mutant OCRL slowed intra-Golgi transport as assessed by 
monitoring endo H kinetics, I used [35S]-sulfate to selectively radiolabel proteins in the TGN. As 
shown in Figure 1.3B, expression of wild type OCRL inhibited TGN to apical delivery of HA, 
whereas mutant OCRL had no effect (Figure 2.3E). Consistent with the selective effect of PI5K 
on HA delivery, neither wild type nor mutant OCRL affected the kinetics of p75 delivery (Figure 
2.3F).  
2.2.4 Knockdown of OCRL in MDCK Cells 
Lowe syndrome patients can have mutations anywhere throughout the coding sequence of 
OCRL1 and often, the result of such mutations is complete loss of OCRL protein expression. 
Therefore, to mimic the conditions in Lowe syndrome patients, I sought to use a knockdown 
approach to silence expression of endogenous OCRL in MDCK cells. The sequence for a canine-
specific OCRL siRNA oligonucleotide (oligo) and a protocol for introducing the oligo into 
MDCK cells were obtained from Dr. Alex Ungewickell (Washington University). The oligo 
GGTTCCCTGCCATTTTTCA contains a single mismatch in the 3’ end of the sense strand that 
has been shown to increase the efficiency of siRNA oligos, presumably by enhancing unwinding 
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and increasing degradation of the target mRNA (205-207). An Amaxa Nucleofector © was used 
to introduce 2.5 or 5µg of control (firefly luciferase) or OCRL siRNA oligo into MDCK cells 
cultured to 50% confluence. After electroporation, cells were either allowed to recover for 1 day 
on a culture dish or plated directly to Transwell filters. After 2-3 days, cells were harvested and 
Western blotted with an antibody against endogenous OCRL to assay the extent of knockdown. 
MDCK cells electroporated with 2.5µg siRNA/0.5 x 106 cells plated directly onto Transwell 
filters exhibited approximately 98% knockdown on day 3, while the other conditions exhibited 
equal or less efficient knockdown (Figure 2.4). In addition to knockdown in polarized MDCK 
cells, significant knockdown was also achieved in a nonpolarized human proximal tubule (HK2) 
cell line (not shown). 
2.2.5 OCRL Knockdown Increases PIP2 Levels and Stimulates Actin Comets 
To determine whether OCRL knockdown recapitulated Lowe syndrome I assayed the published 
cellular phenotypes of Lowe syndrome cells. One report indicated that proximal tubule cells 
from Lowe syndrome patients exhibited increased PIP2 levels (208). Briefly, cellular 
phospholipids were labeled upon incubation with 32P-orthophosphate prior to extraction with 
chloroform-methanol and separation by thin layer chromatography (TLC). MDCK cells lacking 
OCRL had slightly increased PIP2 levels compared with cells treated with control siRNA (Figure 
2.5). While the increase was not statistically significant or as dramatic as that seen with PI5K 
overexpression, it is consistent with the known localization of OCRL in compartments that have 
low relative PIP2 levels.  
Abnormalities in the cytoskeleton have also been described in cells from Lowe syndrome 
patients. Features of this phenotype include decreased stress fibers, increased sensitivity to the 
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actin depolymerizing agent, cytochalasin D, and increased actin comet formation (209;210). I 
examined the actin comet phenotype as increases in PIP2 via PI5K also increase actin comets 
(158). For these experiments, I generated MDCK cells that were stably transfected with cDNA 
encoding GFP-actin. These cells were electroporated with either control or OCRL siRNA and 
then plated onto Transwell filters for 2 days before being grown in culture dishes designed for 
live cell microscopy. Short movies (3-4 min) were taken of random fields and reviewed for the 
presence of actin comets. Analysis revealed that OCRL-knockdown cells had an increased 
frequency of actin comets (~20% of cells) compared to control cells (~4%) (Table 2.1).  
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Figure 2.4 Knockdown of OCRL in polarized MDCK cells 
Low passage MDCK cells grown to 50% confluence were trypsinized and 
resuspended into Amaxa solution mix at a density of 1 x 106 cells/100ul solution. 
100 ul of the cells were mixed with 2.5 or 5 ug of control or OCRL siRNA and 
placed into a cuvette.  Samples were nucleofected using program T-020 and were 
then either put directly onto filters (left) or allowed to recover for 1 day on a 10 
cm dish before being plated to filters for 3 days.  Samples were harvested and 
analyzed by western blot for OCRL and actin as a loading control. Quantitation of 
data using a VersaDoc (BioRad) and Quantity One software were performed. The 
left side of the image is labeled to denote the OCRL and β-actin bands.  Above the 
image, the type of siRNA treatment is denoted and below individual lanes are 
labeled C for control siRNA and O for OCRL siRNA.   

















































MDCK cells were treated with either control or 
OCRL siRNA and plated directly onto filters for 3 
days. Phospholipids were labeled with 32P-
orthophosphate and analyzed by TLC to determine 
relative phospholipids levels. PIP2 values for OCRL 
knockdown were normalized to control in each of 
n=3 independent experiments and mean +/- std 
error is plotted. 
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MDCK cells stably expressing GFP actin were imaged under the indicated 
conditions.  Three minute movies were taken of random frames with either 
a 60X or 100 X oil immersion objective.  Movies were reviewed multiple 
times to determine the percentage of cells with actin comets.  n represents 
the number of cells counted for each condition. For siRNA samples, 
MDCK cells were electroporated with control or OCRL siRNA and plated 
onto filters for two days before being transferred to Bioptech 0.17 mm ΔT 
dishes for imaging. For adenovirus infected samples, MDCK cells seeded 
onto Bioptech dishes were infected with either control AV or AVs 
encoding WA, PI5K, or OCRL (m.o.i. 100-250). The samples were kept in 
0.25 ng/ml DOX overnight to suppress protein expression from the AVs. 
The next day, DOX was thoroughly washed and random fields were 
imaged for 3 min intervals starting 5 h later. The effects of PMA and 
cytochalasin D (cyto D) were determined after a brief treatment with 5 







OCRL siRNA 22 69 
control siRNA 3.6 55 
   
control-AV 7.4 27 
AV-PI5K 27 212 
AV-WA 0 10 
WA+PI5K 0 44 
PI5K + OCRL 0 47 
PI5K + cyto D 0 10 
PMA 31 33 
PI5K + 1-butanol 6.7 15 
PI5K + OCRL 0 47 
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2.2.6 OCRL Knockdown has No Effect on the Biosynthetic Delivery of Influenza HA in 
MDCK or HK2 Cells 
Because increases in cellular PIP2 levels upon overexpression of PI5K stimulated TGN-to-apical 
membrane delivery of HA, knockdown of OCRL might also be expected to stimulate the rate of 
HA delivery. To test this, electroporation of siRNA oligos was used to deplete OCRL from 
MDCK cells. I examined the effect of OCRL knockdown on the delivery of HA from the TGN to 
the apical plasma membrane. In several experiments I detected no significant changes in the rate 
of HA delivery (Figure 2.6 Top). OCRL-null mice show no Lowe syndrome phenotype 
presumably due to compensation by another related PIP2 5-pptase, Inpp5b (211). It is unknown 
whether canine cells lacking OCRL would exhibit the clinical/cellular phenotypes of Lowe 
syndrome or be rescued by compensation. Therefore, to confirm my results in a species known to 
have renal phenotype, I tested the effect of OCRL knockdown on HA delivery in the human 
kidney proximal tubule cell line HK2. Similar to my results in MDCL cells, knockdown of 
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Figure 2.6 TGN to PM delivery of HA is not affected by OCRL 










































MDCK or HK2 cells were treated with either control or OCRL siRNA prior 
to infection with AV-HA. The next day, cells were radiolabeled for 15 min 
and chased for 2 h at 19ºC. Apical or plasma membrane delivery of HA was 
quantitated by cell surface trypsinization at various times after warming to 
37ºC. One representative experiment is shown for both MDCK (top;n=6) 
and HK2 (bottom; n=4) error bars in HK2 graph represent the range.  
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2.3 DISCUSSION 
Here I investigated the role of PIP2 metabolism in polarized biosynthetic traffic. Expression of 
PI5K in polarized MDCK cells markedly stimulated TGN-to-apical delivery of the lipid raft-
associated protein influenza HA, whereas overexpression of OCRL inhibited delivery. Delivery 
of the non-raft associated apical protein p75 and of the basolateral protein VSV-G were 
unaffected by PI5K, and expression of OCRL also had no effect on the rate of apical p75 
delivery. Knockdown of OCRL slightly stimulated PIP2 levels and robustly stimulated the 
formation of actin comets in MDCK cells. However, OCRL knockdown had little to no effect on 
HA delivery, contrary to my initial predictions that delivery would be stimulated. Together these 
data suggest a role for PIP2 in the efficient biosynthetic delivery of a lipid-raft associated protein. 
However the pathological defects observed in Lowe syndrome appear not to be related to defects 
in biosynthetic traffic.  
It is necessary to consider my results in the context of previous studies on the major 
Golgi phosphatidylinositol, PI4P. Overexpression of PI4K increases PI4P levels and inhibits HA 
delivery in MDCK cells (50). The relationship between PI4P and PIP2 in polarized biosynthetic 
traffic may be more complex than a simple precursor-product relationship, as PI4P has many 
functions. A likely scenario is that PI4P and PIP2 function independently to modulate distinct 
steps in membrane transport. 
The roles of OCRL-mediated PIP2 metabolism in the pathology of Lowe syndrome 
remain unclear. The renal Fanconi syndrome common in Lowe patients is likely due to a defect 
in megalin traffic, however, the site of and mechanism of dysfunction remain to be determined. 
OCRL could regulate megalin traffic along the biosynthetic or the endocytic/recycling routes. 
While my data lend less support for a contribution to the biosynthetic route, strong evidence still 
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exists for OCRL-mediated regulation of megalin endocytosis/recycling, including the 
observation that Lowe syndrome patients shed less megalin into their urine (196). While I did not 
identify the compartment to which OCRL localizes in polarized cells, it is possible that the 
supranuclear punctae represent the apical recycling endosome. The apical recycling endosome is 
a compartment unique to polarized epithelial cells which is marked by the small GTPase, Rab11. 
Indeed, this compartment is traversed by megalin in a mechanism dependent on the clathrin 
sorting adaptor, autosomal recessive hypercholesterolemia (ARH) (212). OCRL has been shown 
to interact with clathrin through a conserved clathrin-binding motif, and may function in clathrin-
mediated vesicular traffic of megalin through the endosomal recycling system. 
The site of action of PI5K in TGN-to-apical membrane delivery of HA remains to be 
determined. Whereas no PI5K isoform has been localized to the Golgi complex, the majority of 
the PI5K in polarized MDCK cells was associated with actin filaments near the apical surface, 
close to the supranuclear Golgi complex (Figure 3.1A). There are strong indications that 
apically-destined proteins traverse endosomal intermediates en route to the cell surface 
suggesting the possibility that the PI5K- and OCRL-mediated effects on HA transport might 
occur at post-TGN sites (5;213;214). Overall, my data suggest that PIP2 influences HA traffic 
through modulation of the actin cytoskeleton, but further research is necessary determine the 




*Some text in this chapter, Figure 2.3 and portions of Table 2.1 are published in Guerriero et al. 
JBC 2006 and were used with the permission of the Journal of Biological Chemistry. 
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3.0  THE ROLE OF N-WASP IN BIOSYNTHETIC TRAFFIC 
3.1 INTRODUCTION 
Polarized epithelial cells line the surfaces of our bodies and maintain internal homeostasis 
through the regulation of a selective barrier for pathogens and solutes. Both the actin and 
microtubule cytoskeleton have been implicated in proper biosynthetic membrane traffic. The 
dynamic polymerization of actin into straight or branched filaments regulates diverse cellular 
processes including ion transport, membrane trafficking, and cell migration (215-217). An 
important modulator of actin polymerization is the actin-related protein (Arp)2/3 complex, which 
nucleates the polymerization of actin on existing filaments to create a branched network. 
Members of the Wiskott-Aldrich syndrome protein (WASP) and SCAR/WAVE families of 
proteins activate Arp2/3-mediated actin polymerization, leading to distinct downstream effects. 
For example, Rac-mediated association of WAVE proteins with Arp2/3 regulates the formation 
of lamellopodia, whereas Cdc42- and PIP2-stimulated binding of the ubiquitously expressed 
WASP family member N-WASP to Arp2/3 has been implicated in the intracytoplasmic 
propulsion via actin comets of transport vesicles, organelles, and invading pathogens 
(141;163;218).  
 N-WASP contains multiple domains that contribute to its function, including a WASP 
homology (WH)1 domain, a GTPase binding domain (GBD), a proline-rich region, and a WA 
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domain that binds to both actin and Arp2/3. The protein normally exists in an autoinhibited state 
that is maintained by cis interactions between the GBD and the conserved COOH-terminal WA 
domain. Interaction with GTP-bound Cdc42 and PIP2 relieves the autoinhibition and promotes N-
WASP-mediated activation of Arp2/3.  
Data in chapter 2 show that apical delivery of a lipid raft-associated protein is dependent 
on PIP2. Increases in PIP2 levels upon expression of PI5Ks also leads to production of rapidly 
nucleating branches of actin filaments termed actin comets, which are capable of propelling 
transport vesicles through the cytoplasm (219). N-WASP is activated by PIP2 and transduces 
elevated PIP2 levels into an increased frequency of actin comets (220). N-WASP and Arp2/3 are 
localized to the Golgi complex (among other sites), and a link between actin comets and 
biosynthetic traffic has been previously suggested (158). Activation of Arp2/3 by WASP and 
WAVE proteins can be blocked in vivo by expression of the highly homologous WA domains of 
these proteins, which function as dominant-negative inhibitors (162). In addition, wiskostatin, a 
chemical inhibitor of N-WASP, was recently identified in a high-throughput screen for inhibitors 
of PIP2-mediated actin polymerization (221). In vitro studies demonstrated that wiskostatin binds 
to the GBD of N-WASP, thereby stabilizing the autoinhibited conformation of the protein (178). 
However, the effects of manipulating N-WASP activity on the fidelity or rate of biosynthetic 
transport have not been explored.  
The goal of these studies is to define the requirement for N-WASP in the biosynthetic 
traffic of both apical/basolateral proteins and determine if a link exists between PI5K-stimulated 
apical delivery and N-WASP-mediated actin comets. Here I have examined the effect of 
inhibition of N-WASP/Arp2/3-mediated actin polymerization on biosynthetic delivery in 
polarized MDCK cells. To inhibit N-WASP/Arp2/3 function I used a dominant negative 
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inhibitor of N-WASP, the commercial inhibitor wiskostatin, and an siRNA oligonucleotide 
directed against N-WASP.  
3.2 RESULTS 
3.2.1 PI5K Stimulates Actin Comets in MDCK Cells 
Because PI5K-stimulated actin comets have been implicated in the transport of raft-associated 
proteins (158), I asked whether actin comet-mediated propulsion of HA transport carriers could 
be responsible for the stimulated surface delivery I previously observed. First, I sought to 
determine the relationship between PI5K and actin in fixed cells. MDCK cells were infected with 
AV expressing PI5K, then fixed and processed for indirect immunofluorescence 16 h later. Actin 
filaments were visualized using rhodamine phalloidin and the HA epitope tag on PI5K was 
detected using a monoclonal mouse antibody. PI5K colocalized extensively with actin filaments 
in confocal sections of MDCK cells (Figure 3.1A). This is consistent with previous reports that 
PI5K is found in actin-rich fractions isolated from thrombin-activated platelets (222;223). Next, I 
used a live cell approach to determine whether PI5K stimulates the formation of actin comets. 
Actin comets have not previously been reported in MDCK cells. MDCK cells were seeded on 
glass coverslips, infected with AV encoding PI5K or control AV, and then incubated in the 
presence of 0.25 ng/ml DOX to suppress PI5K expression. The following day, the DOX was 
washed out and cells were microinjected with cDNA encoding GFP-actin. Random fields were 
imaged 5 h later for 4-min intervals using an Olympus IX81 equipped with a 100X Olympus 
UPlanApo objective. Actin comets were defined as rapidly moving bursts of actin followed by a 
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fading tail of presumably depolymerizing actin. Comets generated in MDCK cells were distinct 
but generally smaller than comets described by others using different cell lines, which have been 
reported to be up to 5 µm in length  (158;224;225). Comets were observed in 7.4% of control 
cells and in 27% of the cells overexpressing PI5K (Table 2.1 and Figure 3.1B). 
Additionally, I could increase the frequency of actin comet formation in control cells by 
addition of the protein kinase C activator PMA, which has been previously demonstrated to 
stimulate actin comets in vivo (Table 2.1) (219). PMA also stimulated the rate of apical delivery 
of HA to an extent comparable with that observed upon overexpression of PI5K I reported 
previously (Figure 2.3B). Conversely, addition of 1-butanol, which disrupts phospholipase D-
mediated synthesis of the PI5K activator phosphatidic acid (PA), profoundly inhibited the 
formation of PI5K-stimulated actin comets (Table 2.1) and also blocked delivery of TGN-staged 
HA to the apical surface (Figure 3.2). 1-Butanol-mediated inhibition of PA synthesis has 
previously been implicated in the release of secretory vesicles from the TGN of endocrine cells 
(226). In contrast, t-butanol, which does not affect PA synthesis, had no effect on comet 






















Figure 3.1 PI5K localizes to actin filaments and stimulates actin comet formation 






A, MDCK cells seeded on coverslips were infected with AV-PI5K and processed for 
indirect immunofluorescence the following day to detect actin (with rhodamine 
phalloidin) and the PI5K HA epitope tag (visualized using Alexa 488-conjugated goat 
anti-mouse secondary antibody). Individual confocal sections and a merged image are 
shown. The enlarged insets highlight areas where colocalization of PI5K with short 
actin filaments is clearly evident. Scale bar, 7.5 µM. B, MDCK cells stably expressing 
GFP-actin were infected with AV-PI5K for 6 h and then imaged every 2 s. Enlarged 
areas shown are from individual frames from the supplementary movie. Two comets 
are seen to initiate from the area highlighted by the square over the time course; one at 
108 s, and the other at 146 s. The starting points for each comet are marked with white 
arrowheads in subsequent frames. 
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MDCK cells infected with AV-HA were radiolabeled for 15 min and 
chased for 2 h at 19°C. PMA (5 µg/ml PMA), 1-butanol (n-butanol; 1% 
v/v), or t-butyl alcohol (t-butanol; 1% v/v) were added as indicated 10 
min prior to the end of the chase period and included upon subsequent 
incubation at 37 °C for the indicated times. HA delivery to the apical 
surface was measured by cell surface trypsinization. Similar results 
were obtained in at least three experiments for each condition. 
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3.2.2 The Effect of PI5K on HA Delivery is Mediated through Arp2/3 
If actin comets are involved in the TGN to apical membrane delivery of HA, then blockade of N-
WASP-Arp2/3-mediated actin polymerization would be expected to inhibit HA transport. The 
WA domain of WASP/WAVE family proteins provides the binding sites for actin monomers and 
Arp2/3, and when expressed in isolation is a potent inhibitor of N-WASP function  (158;161). As 
a control, I expressed the W domain, which binds to actin monomers but not to Arp2/3  (161). 
Infection of MDCK cells with AVs encoding W or WA yielded comparable levels of the 
expected protein products (W ~16 kDa; WA ~18 kDa Figure 3.3A). As expected, expression of 
WA abolished PI5K-mediated formation of actin comets, demonstrating effective inhibition of 
Arp2/3 function (Table 2.1). I next examined the effect of the WA domain and PI5K on the 
morphology of polarized, filter-grown MDCK cells. Neither the WA domain nor PI5K had any 
apparent effect on cytoskeletal organization in polarized cells (Figure 3.3B; similar results for W 
domain, not shown). Moreover, neither tight junction morphology nor the positioning and 
morphology of the Golgi complex was affected by expression of these constructs (Figure 3.3, C 
and D), although I did notice in cells expressing very high levels of WA that the Golgi appeared 
to be somewhat dispersed toward the edges of the cells. As observed previously (Figure 2.1), 
PI5K was concentrated near the apical membrane, a region that contains the supranuclear Golgi 
complex and the actin-rich terminal web of these cells (Figure 3.3C).  In contrast, WA was 
diffusely expressed throughout the cytoplasm of polarized MDCK cells (Figure 3.3C). 
I next assessed the impact of W or WA domain expression on early transport of HA 
through the early biosynthetic pathway by monitoring the kinetics of HA acquisition of endo H 
resistance. Expression of WA or W had no discernable effects on the kinetics of HA traffic 
through the early Golgi (data not shown). Next, I examined the effects of these domains on HA 
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delivery from the TGN to the plasma membrane. Expression of WA inhibited kinetics of HA 
delivery to the apical cell surface by approximately ~50–75% relative to control over a 60-min 
chase period (Figure 3.4, A and B). Expression of the W domain did not significantly alter the 
delivery of HA indicating that expression of WA was not generally disrupting actin-driven 
processes. As with PI5K expression, the effect of WA on HA delivery was on rate rather than 
sorting, as HA surface polarity measured after long chase times was not compromised (not 
shown). The stimulatory and inhibitory effects of PI5K and WA on HA delivery kinetics were 
highly reproducible, and were statistically significant as assessed by Student's t test analysis of 
multiple experiments (Figure 3.4B). The inhibitory effect of the WA domain was specific for 
lipid raft-enriched apical cargo, as there was no effect of the domain on the apical delivery of p75 
(Figure 3.4C). Moreover, expression of WA had no effect on the delivery of the basolateral 
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Figure 3.3 Expression of PI5K or the WA domain of Scar1 does not 


















































A, MDCK cells were mock-infected or infected with AVs encoding the W or WA domain of 
Scar1, radiolabeled for 1 h, and lysates run on a 15% SDS gel. The positions of molecular weight 
markers (MW) are shown. W and WA migrate at their expected molecular masses (16 and 18 
kDa, respectively). B, expression of PI5K or WA does not disrupt actin morphology in polarized 
MDCK cells. Confocal sections from the apical, lateral, and basal portions of rhodamine 
phalloidin-labeled PI5K- or WA-expressing cells are shown. C, expression of PI5K or WA does 
not alter tight junction morphology of MDCK cells. Filter-grown cells were infected with either 
PI5K- or WA-expressing AVs. Samples were fixed and processed for indirect 
immunofluorescence to detect ZO-1, and PI5K or WA. ZO-1 was detected using secondary 
antibody coupled to Alexa 647 and PI5K or WA was visualized using Alexa 488-conjugated goat 
anti-mouse secondary antibody. Rhodamine phalloidin was included in the secondary antibody 
incubations to detect filamentous actin. Samples were imaged by confocal microscopy, and five 
slices (0.5 µm apart) through the region of the tight junctions were overlaid to make a maximum 
projection. Individual projections and merged xyz and xzy images are shown. D, samples infected 
as in B were stained with rhodamine phalloidin and monoclonal anti-giantin antibody followed by 
Alexa 488-conjugated secondary antibody. A projection of five sections taken through the Golgi 
region is shown. AV-infected cells (asterisks) were identified by co-labeling to detect PI5K (left 
panel) or WA (right panel). Scale bar = 7.5 µm for all xyz sections shown. 
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A, WA inhibits apical delivery of TGN-staged HA. The kinetics of HA surface delivery 
were quantitated in MDCK cells co-infected with AV-HA, and either control AV or WA-, 
W-, or PI5K-expressing AVs as described previously. B, quantitation of the effects of 
WA, W, and PI5K on HA delivery. The bar graph shows the mean % of total HA (± S.E.) 
at the apical surface after a 60-min chase in at least 8 experiments for each condition. * 
denotes statistical significance from control measured using Student's t test (WA, n = 8, p 
0.001; PI5K, n = 13, p = 0.001). C, expression of WA has no effect on p75 delivery to 
the apical surface. Kinetics of p75 delivery were measured as described in the legend to 
Figure 2.3. Similar results were obtained in three experiments. D, WA does not affect 
basolateral delivery of TGN-staged VSV-G. MDCK cells were co-infected with VSV-G, 
and control, WA- or W-expressing AVs. VSV-G delivery to the basolateral cell surface 
was determined by cell surface biotinylation. Each experiment was performed using 
triplicate or quadruplicate samples, and mean ± S.E. from the indicated number of 
experiments is plotted. Data for control at 0 and 60 min are the same as those shown in 
Figure 2.3D. * denotes significant difference from control at 0 min (control at 0 min, n = 
3; control at 60 min, n = 8, p = 0.02; WA, n = 7, p = 0.005; W, n = 7, p = 0.03; PI5K, n = 
4, p = 0.03). 
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3.2.3 The Effect of Wiskostatin on Membrane Traffic in vivo 
Expression of the WA domain of WAVE1 indicated that N-WASP was involved in biosynthetic 
traffic by significantly decreasing the rate of delivery of lipid-raft cargo, without changing the 
delivery rate of other types of apical proteins or a basolateral protein. However, the WA domain 
could also inhibit WAVE proteins, in addition to N-WASP. A rapidly growing number of 
publications have reported the use of wiskostatin to assess the role of N-WASP in various 
cellular processes (227-231). In some cases, the effects of wiskostatin on these pathways were 
interpreted as evidence for known or novel roles for N-WASP in cellular pathways. For example, 
addition of 50 µM wiskostatin to intestinal epithelial cells was found to inhibit the formation of 
nascent adherens junctions (227). A more recent report found that addition of 10 µM wiskostatin 
to B16-F1 cells rapidly dispersed mTuba-containing punctae and inhibited membrane ruffling 
(229). Another report used 50 µM wiskostatin to show that N-WASP-mediated vesicle motility is 
a downstream event in nonclassic apoptosis triggered by the adenoviral protein E4orf4  (230). 
Finally, Haller et al.  (228) used 40 µM wiskostatin to demonstrate that N-WASP activation is 
important for the maturation of immunologic synapses on T-lymphocyte stimulation. In order to 
determine the role of N-WASP in polarized biosynthetic traffic, I tested the effect of wiskostatin 
treatment on the biosynthetic delivery of HA. 
3.2.3.1 Wiskostatin Inhibits Arp2/3-dependent Apical Biosynthetic Traffic 
I chose to use wiskostatin as a more specific inhibitor of N-WASP in order to confirm my results 
using the WA domain. On the basis of my data in Chapter 2, I hypothesized that wiskostatin 
would inhibit HA delivery to a level comparable to that of WA expression. HA-expressing 
MDCK cells (control or overexpressing PI5K) were radiolabeled for 15 min, incubated at 19ºC to 
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stage newly synthesized membrane proteins in the TGN, and then warmed to 37ºC, and HA 
surface delivery was monitored after 1 h with a surface trypsinization assay as described in 
Henkel et al. 2000 (232) As observed previously, HA delivery was stimulated relative to control 
in cells overexpressing PI5K and inhibited by expression of WA (Figure 3.5A). Inclusion of 50 
µM wiskostatin during the 37ºC chase caused a profound inhibition of HA delivery in both 
control and PI5K-overexpressing cells. In contrast, the effect of WA domain expression on HA 
delivery was largely rescued by PI5K coexpression. 
Next I examined the dose dependence of wiskostatin's effect on HA delivery. HA-
expressing MDCK cells were radiolabeled, HA was staged in the TGN at 19ºC for 2 h, and 10–
50 µM wiskostatin or vehicle alone was added to the cells before warming to 37ºC and 
quantitation of surface delivery kinetics. Additionally, some samples were treated with 50 µM 
wiskostatin during the 2-h stage and then washed extensively before warming to 37ºC to assess 
the reversibility of wiskostatin's effect (Figure 3.5B). HA surface delivery was unaffected by 
acute addition of 10 µM wiskostatin, but treatment with higher concentrations (25 or 50 µM) 
resulted in a virtual blockade in apical delivery. Moreover, the effect of wiskostatin treatment 
was irreversible over this period, because washout of the drug before warming failed to restore 
























Figure 3.5 Wiskostatin inhibits neuronal Wiskott-Aldrich syndrome protein (N-






A: polarized Madin-Darby canine kidney (MDCK) cells were infected with replication-
defective recombinant adenoviruses encoding influenza hemagglutinin (HA) and 
phosphatidylinositol 4-phosphate 5-kinase (PI5K) and/or a construct encoding a dominant-
negative inhibitor of N-WASP function (WA) as indicated. The following day, cells were 
radiolabeled for 15 min and chased for 2 h at 19°C to accumulate newly synthesized 
proteins in the trans-Golgi network. Apical delivery of HA was quantitated after warming to 
37°C for 1 h in the presence or absence of 50 µM wiskostatin (wisk). B: cells were prepared 
as in A and were treated with wiskostatin at the indicated concentrations or with 50 µM 
wiskostatin during the 2-h chase followed by washout before warming to 37°C. The results 
of a single experiment in each case are shown. PM, plasma membrane. 
  74 
3.2.3.2  Wiskostatin Inhibits N-WASP-independent Steps in Transport 
As a control to ensure the selectivity of wiskostatin for N-WASP-dependent cellular processes, I 
examined the effect of this drug on early steps in biosynthetic transport that are thought to be N-
WASP-independent (233;234). MDCK cells expressing HA were starved in methionine-free 
medium, radiolabeled for 15 min, incubated for 2 h at 19ºC to accumulate mature (sialylated) HA 
in the TGN, and then either solubilized or warmed to 37°C for 1 h, and surface delivery was 
assessed (Figure 3.6). Wiskostatin (50, 25, or 10 µM) was added at various stages during this 
pulse-chase protocol. Addition of wiskostatin for 2 h at 19ºC after the radiolabeling period 
decreased the accumulation of sialylated HA compared with a mock-treated sample in a dose-
dependent manner (Figure 3.6, lanes C and A, respectively), consistent with inhibition of either 
intra-Golgi transport or the cellular glycosylation processing machinery. On subsequent warming 
to 37ºC in the continued presence of wiskostatin, only 1.8% (50 µM), 2.7% (25 µM), or 20% (10 
µM) of the total HA reached the cell surface in wiskostatin-treated cells (Figure 3.6, lane D). In 
contrast, 53% of the total HA in mock-treated samples reached the surface during this period, as 
assessed by the susceptibility of HA to cleavage into HA1 and HA2 fragments on surface 
trypsinization (Figure 3.6, lane E). Moreover, when wiskostatin was added to cells during the 30-
min starvation period and in subsequent steps, I observed a loss in the synthesis of radiolabeled 
HA, particularly at the higher wiskostatin concentrations (Figure 3.6, lane B). In cells treated 
with 50 µM wiskostatin during the starve and pulse, HA recovery was decreased by 92% 
compared with control, whereas 25 µM and 10 µM wiskostatin decreased recovery by 28% and 
7.3%, respectively. Thus wiskostatin appears to inhibit uptake of radioactive methionine and/or 
disrupt protein synthesis. 
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HA-expressing MDCK cells were starved (S) for 30 min, radiolabeled (P) for 15 min, 
incubated for 2 h at 19°C ,and then either solubilized immediately (samples in lanes A, B, 
and C) or incubated for 1 h at 37°C and trypsinized to quantitate surface delivery of HA 
before solubilization. HA was visualized after immunoprecipitation and SDS-PAGE. 
Samples in lanes A and E were mock-treated, whereas wiskostatin was added to the 
remaining samples beginning at the starve (lane B) or at the start of the 19°C incubation 
(lanes C and D). The migration of immature (ns) and sialylated (sial) forms of HA as well 
as the cleavage products generated on surface trypsinization (HA1 and HA2) are 
indicated. Surface delivery of HA in the samples in lanes D and E was 1.8% (50 µM), 
2.7% (25 µM), 20% (10 µM), and 53% (control, lane E) of the total HA. Similar results 
were obtained in 2 experiments. 
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My results described above suggested that wiskostatin inhibits multiple steps along the 
biosynthetic pathway. To examine its role in postendocytic transport, I measured the effect of 
wiskostatin on basolateral-to-apical transcytosis of IgA in MDCK cells stably expressing the 
rabbit pIgR. In this multistep pathway, IgA binds to pIgR at the basolateral cell surface and is 
transported across the cell, where pIgR is cleaved to release a soluble IgA-pIgR complex into the 
apical medium. Transcytosis of IgA in these cells has previously been demonstrated to be actin-
dependent  (235). MDCK cells were incubated for 10 min at 37ºC with basolaterally added 125I-
IgA, washed extensively on ice, and then warmed to 37ºC in the presence or absence of the 
indicated concentrations of wiskostatin. Transcytosis was quantitated as the release of 125I-IgA 
into the apical medium as described in Henkel et al. 1998 (236). Transcytosis was rapid and 
efficient, approaching 80% of the internalized 125I-IgA within 1 h of warm-up (Figure 3.7). In 
contrast, transcytosis was rapidly inhibited in a dose-dependent manner when wiskostatin was 
added to the cells at the start of the 37°C warm-up period. Inhibition of 125I-IgA transcytosis by 
wiskostatin could reflect a block in membrane traffic or alternatively, inhibition of the 
proteolysis step required for the apical release of secretory component. However, when 50 µM 
wiskostatin was added to cells before the incubation with 125I-IgA, internalization of the 
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Polarized MDCK cells were incubated with basolaterally added 125I-labeled IgA for 10 min at 
37°C and then washed extensively on ice. Apical release of 125I-IgA was quantitated on 
warming to 37°C in the presence or absence of the indicated concentrations of wiskostatin 
added after IgA internalization. Means ± SD of triplicate samples are plotted. 
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3.2.3.3 Wiskostatin Decreases Cellular ATP Levels 
 It was shown previously that depletion of cellular ATP by energy poisons such as sodium azide 
dramatically inhibits protein processing and secretion (237). The rapid and profound effects of 
wiskostatin on multiple steps in protein synthesis, endocytosis, and membrane traffic suggested 
that this drug may similarly perturb cellular ATP levels. To examine this possibility, MDCK 
cells plated in 12-well dishes were treated with wiskostatin at 10, 25, or 50 µM or vehicle for 0–1 
h at 37°C. ATP was extracted and quantified with a luminometry-based assay (Figure 3.8). 
Addition of 25 µM and 50 µM wiskostatin, respectively, resulted in the rapid and nearly 
complete loss of cellular ATP, decreasing the levels to 57% and 30% of control within 15 min 
and to 18% and 9.4% of control within 1 h. Treatment with 2% sodium azide resulted in a 
comparable drop in ATP levels, to 4.6% of control after 1 h of treatment (not shown). 
Wiskostatin added at a lower concentration (10 µM) had a less dramatic effect on cellular ATP in 
MDCK cells (84% and 81% of control at 15 min and 1 h, respectively). Washout of the drug for 
30 min after a 1 h treatment with any concentration of wiskostatin did not restore normal ATP 
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MDCK cells plated in 12-well dishes were treated with vehicle alone or with wiskostatin at 
50, 25, or 10 µM for the indicated time periods. Some drug-treated samples were washed 
extensively after 1 h of treatment and incubated for an additional 30 min (washout) before 
assessment of cellular ATP levels as described in materials and methods. The dose- and time-
dependent effect of wiskostatin on ATP levels was normalized to control cells and plotted 
(means ± SE of 3 independent experiments). *p < 0.05 compared with control based on paired 
t-test of log-transformed raw data. Treatment with the known energy poison sodium azide 
(2%) decreased cellular ATP levels to 4.6% of control after 1 h of treatment (not shown). 
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3.2.4 N-WASP Knockdown Inhibits HA Delivery 
The data generated with wiskostatin did not convincingly support a role for N-WASP in 
biosynthetic traffic, as wiskostatin had multiple off-target effects in vivo. To more specifically 
probe for N-WASP-dependent effects, I chose to use siRNA. This approach was not chosen 
initially because knockdown in polarized cells is notoriously difficult, but new approaches 
including siRNA electroporation became available during the course of my work. I designed an 
siRNA targeting canine N-WASP based on a previously published siRNA oligo (238). I assessed 
the extent of knockdown using Western blotting and found only modest knockdown, 15-40% 
(Figure 3.9). However, when I examined the effect of N-WASP knockdown on polarized 
biosynthetic traffic I found that despite the modest knockdown, the rate of biosynthetic delivery 
was inhibited by up to 53% relative to control (Figure 3.10). These data confirm my initial 
observation and support my conclusion that N-WASP-mediated actin polymerization plays an 
important role in the rate of biosynthetic delivery of lipid raft-associated proteins. 
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Low passage MDCK cells grown to 50% confluence were trypsinized and resuspended 
into Amaxa solution mix at a density of 1 x 106 cells/100μl solution. 100 ul of the cells 
were mixed with 2.5 or 5 ug of control or OCRL siRNA and placed into a cuvette.  
Samples were nucleofected using program T-020 and were then either put directly onto 
filters for either two or 3 days.  Samples were harvested and analyzed by western blot 
for N-WASP and β-actin as a loading control. Quantitation of data using a VersaDoc 
(BioRad) and Quantity One software were performed.  The left side of the image is 
labeled to denote the N-WASP and β-actin bands.  Above the image, the days of siRNA 
treatment is denoted and below individual lanes are labeled C for control siRNA and 
NW for N-WASP siRNA.   
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C siRNA + Cntl AV
C siRNA + PI5K AV
NW siRNA + Cntl AV
MDCK cells were electroporated in buffer containing either control (C) or N-WASP 
(NW) siRNA oligo. The cells were then seeded onto Transwell filters and infected 
with control(Cntl)-AV or PI5K-AV before the experiment on day 3.  HA infected 
cells were starved, pulsed with 35S-TransLabel and chased for 2 h. Surface delivery 
was measured using a cell surface trypsinization assay. The graph represents one 
experiment from n=3 independent experiments with similar results. 
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3.2.5 HA is Associated with Actin Comets in MDCK Cells 
The data described above suggested the selective involvement of PI5K-stimulated, N-WASP-
dependent actin comets in the TGN-to-apical membrane delivery of HA. To test whether newly 
synthesized HA could be visualized in association with actin comets, MDCK cells seeded on 
glass coverslips were co-infected with AV-PI5K and AV-HA for 8 h, and then incubated at 19ºC 
for 2.5 h to accumulate HA in the TGN. Samples were then warmed to 37ºC for 30 min, fixed, 
and processed for indirect immunofluorescence to visualize actin, HA, and PI5K (Figure 3.11). 
Numerous actin comets were detected in these cells, many of which stained positively for both 
PI5K and HA (Figure 3.11, arrows). In 25 images I observed 71 comets of which 20 (28%) were 
positive for both HA and PI5K. By contrast, in 20 images I observed 57 comets of which only 2 
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Figure 3.11 HA and PI5K are associated with actin comets in MDCK cells. 
 
MDCK cells grown on coverslips were co-infected with AV-HA and either control or 
PI5K for 8 h. HA was staged in the TGN for 2.5 h and 19°C, then warmed to 37°C for 
30 min prior to fixation and processing for indirect immunofluorescence. Actin was 
stained using rhodamine phalloidin; HA was visualized using monoclonal antibody 
Fc125 followed by a Alexa 488-conjugated goat anti-mouse, and the PI5K HA epitope 
tag was visualized using a polyclonal antibody followed by Alexa 647-conjugated goat 
anti-rabbit. Individual confocal sections for each channel and a merged image 
demonstrating several examples of actin comets that co-label with HA and PI5K 
(marked with arrows) are shown. Scale bar, 7.5 µm. 
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3.3 DISCUSSION 
I investigated the role of N-WASP in polarized biosynthetic traffic downstream of PI5K activity. 
I found that MDCK cells are capable of forming actin comets and that expression of AV-PI5K 
dramatically increases the rate of actin comet formation. Moreover, pharmacological treatments 
that modify actin comets, such as PMA or 1-butanol have parallel effects on actin comet 
formation and HA delivery. Inhibition of Arp2/3 via expression of the WAVE1 WA domain 
significantly inhibited the rate of HA delivery, while having no effect on either another apical 
marker (p75) or a basolateral maker (VSV-G). Wiskostatin was used to specifically test for N-
WASP involvement in comet formation, but was found to have non-specific effects on 
membrane traffic. Ultimately, knockdown of N-WASP indicated that N-WASP is important in 
HA delivery, and immunofluorescence microscopy confirmed that both HA and PI5K were 
found associated with actin comets in fixed cells. Together these biochemical and imaging data 
provide strong evidence for a novel role for actin comets in polarized biosynthetic delivery of 
lipid raft-associated proteins. 
3.3.1 The Role of Actin in Biosynthetic Traffic 
Numerous studies have documented the roles of actin in intra- and post-Golgi transport (239). 
These have ranged from observations of the presence of actin and actin-associated proteins 
associated with the Golgi complex (240-242) to more mechanistic insights into the potential roles 
of actin polymerization in biosynthetic traffic (217). Interestingly, the ADP-ribosylation factor, 
Arf1 appears to be important for actin assembly on Golgi membranes  (241) and this process 
requires coatomer-bound Cdc42 and activation of the Arp2/3 complex (243;244). Cdc42 may 
  86 
also regulate recruitment of dynein to coatomer protein complex I vesicles (245). However, the 
consequences of these signaling cascades on intra-Golgi membrane traffic are not clear. I found 
no effect of expression of either PI5K or the WA domain of WAVE1 on intra-Golgi transport 
kinetics, suggesting that PIP2- and Arp2/3-mediated actin polymerization are not required for the 
transport or maturation of cargo.  
Arf-dependent actin recruitment has also been implicated in post-Golgi transport. 
Recruitment to Golgi membranes of the actin-binding protein cortactin was shown to be Arf-
dependent, and disruption of this complex in BHK cells had profound effects on the surface 
delivery of VSV-G without affecting intra-Golgi transport (246). However, our laboratory has 
previously demonstrated that TGN export of HA occurs independently of Arf function (6). 
Modulation of actin dynamics by the clathrin- and actin-binding protein Hip1R has also been 
suggested to regulate formation and release of clathrin-coated vesicles from the TGN (247).  
3.3.2 The Use of Wiskostatin as a Probe for N-WASP Function 
The studies described in this chapter suggest that wiskostatin has global and likely nonspecific 
effects on membrane traffic and other pathways. Treatment of polarized MDCK cells with this 
drug inhibited protein synthesis and maturation and disrupted both biosynthetic and 
postendocytic traffic. The effects of wiskostatin on these transport steps were dose dependent, 
irreversible, and roughly paralleled in magnitude the effects of the drug on cellular ATP levels. 
Notably, however, gross cellular morphology and actin structure were not visibly altered after a 1 
h incubation with 50 µM wiskostatin, indicating that cell death was not occurring during this 
period (data not shown).  
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I can only speculate as to the mechanism by which wiskostatin perturbs cellular ATP 
levels. Metabolic energy poisons fall into one of four classes, the first two of which are most 
common: 1) inhibitors of electron transport, 2) uncouplers/ionophores, 3) inhibitors of ATP 
synthase, and 4) inhibitors of transport systems (248). Members of the first group include 
rotenone, cyanide, and sodium azide, which block electron transport by interacting irreversibly or 
competitively with components of the electron transport chain (249;250). The second group 
includes 2,4-dinitrophenol (DNP) and carbonyl cyanide p-trifluoromethoxyphenylhydrazone 
(FCCP), which disrupt the proton gradient by acting as proton ionophores (251;252). The 
aromatic structure of wiskostatin suggests the possibility that, like DNP, it may also disrupt 
membrane integrity; however, elucidating the mechanism by which this drug interferes with 
cellular ATP homeostasis requires further study.  
The effect of wiskostatin on most cellular transport steps and on ATP levels demonstrated 
a steep dose-dependent response at concentrations between 10 and 25 µM. Treatment with 10 
µM wiskostatin decreased ATP levels by only ~20% after a 1-h treatment and had comparable 
effects on protein synthesis and maturation when added acutely to cells (Figure 3.6, lanes B and 
C). In contrast, treatment with 25 µM wiskostatin decreased ATP levels by 80% over this time 
period. Interestingly, 10 µM wiskostatin did not affect the efficiency of surface delivery when 
added acutely after cargo had been prestaged in the TGN (Figure 3.5); however, surface delivery 
(but not HA maturation) was severely compromised (by 80%) when the drug was added at the 
start of the 2-h TGN staging period at 19ºC (Figure 3.6, lane D). A possible explanation is that 
post-Golgi transport may be insensitive to acute ATP depletion compared with other steps; 
however, longer incubations with this concentration of wiskostatin might sufficiently affect ATP 
levels to inhibit this step or otherwise disrupt other cellular functions required for efficient 
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membrane traffic. Ironically, it is this very step in membrane transport, namely TGN-to-apical 
surface delivery of HA, that I found to be N-WASP-dependent based on my studies using the 
WA domain (234). Previously published studies have utilized variable concentrations of 
wiskostatin, ranging from 10 to 50 µM (227-231). In all of these reports, rapid and profound 
effects on the particular cellular function being studied were noted and ascribed to selective 
inhibition of an N-WASP-dependent pathway. Given the global effects of wiskostatin on cellular 
transport processes and ATP levels, however, it is clear that this drug is inappropriate for in vivo 
studies aimed at selectively perturbing N-WASP function, or for potential therapeutic use as 
previously suggested (221). Moreover, novel roles ascribed to N-WASP in cellular pathways 
based solely on in vivo effects observed with wiskostatin merit careful reexamination.  
3.3.3 The Role of Actin in Polarized Biosynthetic Traffic 
Specific roles for actin polymerization in the transport of apical proteins, and lipid raft-associated 
cargo in particular, have previously been suggested. Rozelle et al.  (158) observed that newly 
synthesized HA was preferentially localized to the tips of short polymers of actin reminiscent of 
N-WASP-dependent comets in PI5K-overexpressing cells. In support of this, PIP2 has been 
suggested to be enriched in lipid rafts (253-255) although this conclusion has recently been 
challenged (31;256). Moreover, my observation that expression of either PI5K or WA had no 
effect on apical delivery of a non-raft-associated protein adds support to the idea that transport of 
raft-associated and raft-independent proteins is differentially regulated. Jacob et al. (9;199) have 
previously suggested that biosynthetic transport carriers containing the lipid raft-associated 
hydrolase sucrase isomaltase traffic via actin cables to the cell surface, whereas carriers enriched 
in the non-raft apical protein lactase-phlorizin hydrolase traffic in separate carriers in an actin-
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independent manner. Recently, the same group identified α-kinase 1, which phosphorylates the 
motor protein myosin I, as a component of sucrase isomaltase but not lactase-phlorizin 
hydrolase-containing vesicles and demonstrated a role for this motor in apical delivery of sucrase 
isomaltase (257). Whether α-kinase 1 activity is important for the PI5K-mediated stimulation of 
HA delivery I observed is not known; however, in a parallel scenario, both myosin motors and N-
WASP-Arp2/3-mediated actin polymerization have been suggested as mechanisms that propel 
internalized endocytic vesicles through the actin-rich cortical cytoskeleton (154;219;258-260). 
3.3.4 Concerted Cytoskeletal Function in Polarized Membrane Traffic 
Regardless of the role (s) for actin polymerization in apical membrane traffic, it is likely that the 
long-range directionality of biosynthetic membrane traffic is provided ultimately by the 
microtubule network. Previous biochemical studies have demonstrated a role for microtubules in 
polarized membrane transport in MDCK cells (261-264). In addition, live cell imaging has 
clearly shown that VSV-G-containing transport carriers move to the plasma membrane on 
microtubule tracks (265;266). I found that disruption of actin with cytochalasin D or by 
expression of WA in concert with nocodazole treatment virtually abolished delivery of HA to the 
apical membrane, and ultimately disrupted the polarity of delivery (not shown). In contrast, 
expression of WA alone had no effect on HA polarity. My data are reminiscent of studies by 
Maples et al. who demonstrated a concerted role for actin and microtubules in basolateral to 
apical transcytosis of the polymeric immunoglobulin receptor (235). My results do not 
necessarily suggest that actin comets are obligatory for apical delivery, but rather that they may 
facilitate apical transport of HA under some conditions. I hypothesize that actin-based movement 
of HA-containing transport carriers facilitates their access to microtubule tracks that provide the 
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directionality for efficient transport to the apical membrane, and/or ferries transport carriers 

















*Some text in this chapter and Figures 3.1, 3.2, 3.3, 3.4, and 3.11 are published in Guerriero et 
al. JBC 2006 and were used with the permission of the Journal of Biological Chemistry. 
**Some text in this chapter and Figures 3.5, 3.6, 3.7, and 3.8 are published in Guerriero et al. 
Am J Physiol Cell Physiol 2007 and were used with the permission of the American Journal of 
Physiology Cell Physiology. 
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4.0     CONCLUSION 
Protein sorting along the biosynthetic pathway is a multi-step process that requires the 
coordinated action of both proteins and lipids. In recent years there has been an increasing 
appreciation of the role of lipid metabolism in membrane trafficking pathways. Diseases of 
phosphatidylinositol metabolism can disrupt physiological processes like renal protein 
reabsorption, as observed in Lowe Syndrome, which highlights the importance of lipid 
metabolism for normal membrane traffic in polarized kidney cells.  
In this dissertation, I investigated the role of PIP2 metabolism in biosynthetic traffic of 
polarized MDCK cells. Previously, apical biosynthetic traffic was shown to be regulated by 
levels of PI4P in the Golgi (50). Many lines of evidence also point toward a role for PIP2 
metabolism in normal Golgi function. I found that overexpression of the α isoform of PI5K 
stimulates the rate of biosynthetic traffic of the lipid raft-associated marker HA. Moreover, 
decreasing cellular PIP2 (via OCRL overexpression) inhibits the rate of HA delivery, 
demonstrating a correlation between PIP2 levels and biosynthetic traffic of HA. While 
knockdown of OCRL did not affect biosynthetic traffic, a clear role exists for PIP2 in surface 
delivery of newly synthesized HA.  
Actin participates in and provides the motile force for many membrane trafficking events, 
including endocytosis and pathogen motility. An upstream controller of actin-based motility is 
PIP2, which can recruit nucleation promoting factors (NPFs) to the surface of the motile 
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structure. One such NPF, N-WASP is responsible for branched actin filament formation via the 
Arp2/3 complex and is activated by PIP2. Using multiple approaches, including dominant 
negative inhibitors and siRNA-mediated knockdown, I demonstrated that N-WASP is required 
for HA delivery. Moreover, I found that PI5K and HA are associated with actin comets in 
MDCK cells, linking PI5K-stimulated HA delivery, PIP2 metabolism, and actin comet formation. 
Together, my data support the discovery of a novel role for PIP2 metabolism and N-WASP-
mediated actin comets in the efficient polarized biosynthetic traffic of lipid raft-associated 
proteins. Below I discuss the implications of my findings with respect to our understanding of 
polarized membrane traffic and the pathogenesis of Lowe syndrome.   
4.1 THE FUNCTION OF OCRL IN POLARIZED EPITHELIAL CELLS 
I found that overexpression of OCRL inhibits the rate of HA delivery, likely due to a decrease in 
cellular PIP2 levels. To examine the consequences of loss of OCRL I used siRNA-mediated 
knockdown to silence endogenous canine OCRL. OCRL knockdown stimulated the rate of actin 
comet formation similar to PI5K overexpression. In addition, knockdown slightly increased PIP2 
levels. Therefore, I predicted that knockdown may also stimulate HA delivery as I saw with 
PI5K overexpression, but this was not observed. There are several possible explanations for why 
siRNA knockdown of OCRL did not produce to the hypothesized effects on biosynthetic 
delivery.  
One interpretation for the increase in actin comets without a concomitant trafficking 
phenotype is that actin comets resulting from OCRL knockdown originate from a different 
compartment than those stimulated by PI5K overexpression. In live cell microscopy studies I 
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found that actin comets resulting from PI5K seem to originate from a region localized near the 
TGN (not shown).  While I was unable to directly see comets emanating from the TGN, these 
data do suggest that comets form in close proximity to the Golgi complex. Comets generated by 
OCRL knockdown may instead form on endosomes or endocytic vesicles. Live cell microscopy 
could be used to test if comets in OCRL-deficient cells are more frequently associated with 
endosomes than comets in PI5K-overexpressing cells. The percentage of comets on endocytic 
structures could be determined by monitoring actin comet formation in cells preloaded with a 
fluorescently-tagged dextran to mark endocytic compartments. I predict that OCRL comets will 
more frequently propel structures loaded with dextran than PI5K-stimulated comets. Another 
approach to test the origin of OCRL-stimulated comets would be to look for association of 
comets with biosynthetic cargo in fixed cells. I found that TGN-staged HA was enriched on 
PI5K-induced actin comets when compared to another apical marker p75. Therefore, a similar 
approach could be used in OCRL KD cells and determine if OCRL comets are associated with 
HA to a greater or lesser extent than PI5K-stimulated comets. I found that ~30% of PI5K comets 
associate with HA, and I predict that OCRL-stimulated comets are less likely to be associated 
with HA. 
A second interpretation of my results is that OCRL’s regulation of actin comet formation 
is not linked to the role of PIP2 in biosynthetic membrane traffic. OCRL interacts with clathrin 
and AP-2 and has been found associated with CCVs providing evidence that OCRL may be 
important for endocytic traffic (74). Additionally, OCRL interacts with the Rab5 effector 
APPL1, which is found on a subset of peripheral early endosomes (76). Total internal reflection 
fluorescence microscopy studies showed that a small fraction of OCRL is recruited to CCPs and 
then moves towards APPL1 positive early endosomes after endocytosis. APPL1 has been 
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described as an adaptor protein for cell surface receptors such as megalin, with which it interacts 
as a part of a larger protein complex (267). Therefore, the role of OCRL in vesicular traffic may 
be more like that of synaptojanin which is important for uncoating of endocytic CCVs. If this 
were true, then it is possible that actin comet formation on vesicles is only a secondary effect due 
to an accumulation of PIP2 on endocytic vesicles. To test if the comets seen in Lowe syndrome 
cells and OCRL KD are important for membrane traffic, trafficking experiments could be 
performed under conditions that inhibit actin comets. Megalin endocytosis or CI-MPR 
trafficking could be assayed in knockdown cells with or without the addition of N-WASP siRNA 
to inhibit comet formation. I predict that N-WASP siRNA will have no effect on OCRL-
mediated membrane traffic. However, these experiments may be difficult to interpret as the 
endocytosis of some surface receptors is N-WASP-dependent (259). If OCRL is necessary for 
uncoating of a subset of endocytic vesicles then a defect in this process could lead to problems 
with vesicle endocytosis or recycling similar to what has been shown in neurons of synaptojanin 
1-deficinet mice which accumulate CCVs near the synapse (268).   
It is also plausible that the loss of OCRL does not influence PIP2 levels enough to change 
the rate of biosynthetic delivery. Indeed, increases in PIP2 upon OCRL knockdown are modest 
(~130% of control) and not statistically significant, compared to PI5K overexpression (~225% of 
control). Since OCRL does not localize to the plasma membrane at steady state, it is reasonable 
to assume that only modest changes in PIP2 would be observed after knockdown. However, 
published studies in primary proximal tubule cells from Lowe syndrome patients report a large 
increase in PIP2 (~190% of control) (208). Why do I observe only small increases in PIP2 levels 
upon OCRL knockdown? One explanation may be that loss of OCRL could be compensated by 
another enzyme(s). In support of this, OCRL knockout mice have no discernable Lowe 
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syndrome phenotype, possibly because mice have higher expression of the OCRL-homologue 
Inpp5b than humans. OCRL/Inpp5b double knockout mice are embryonically lethal, suggesting 
that while Inpp5b can compensate for loss of OCRL, the loss of both enzymes is debilitating 
(211). To test the possibility that Inpp5b can compensate for OCRL, siRNA could be used to 
simultaneously knock down OCRL and Inpp5b in polarized MDCK cells. If Inpp5b is 
compensating for loss of OCRL, then double knockdown should more potently increase PIP2 
levels than OCRL knockdown alone and effect biosynthetic delivery.  
One caveat of my OCRL knockdown studies is the reliance on immortalized cell lines to 
recapitulate in vivo disease phenotypes. Cultured cells are less than ideal, as often these systems 
behave differently than they would within an organ due to genetic drift (269). Indeed, while HK2 
cells are relevant for studies involving OCRL and megalin because of their proximal tubular 
identity, they do not form a polarized monolayer and also express much less megalin than in vivo 
proximal tubules (Linton Traub, personal communication). Therefore, it may ultimately be 
necessary to move to an in vivo system, such as an animal model to study OCRL. However, as 
noted above, knockout of OCRL in mice does not result in a disease phenotype (211). 
Unpublished observations from our collaborator Dr. Robert Nussbaum suggest that this 
difference between humans and mice stems from alternate splicing of mouse Inpp5b. In mice 
50% of the Inpp5b mRNA uses an alternate splice site, thus producing a mixed population of 
Inpp5b protein. It is hypothesized that the alternatively spliced mouse Inpp5b is more capable 
than human Inpp5b at compensating for loss of OCRL. To test this hypothesis, OCRL/Inpp5b 
knockout mice have recently been engineered to express a single copy of human Inpp5b from a 
bacterial artificial chromosome. The goal of this experiment is to determine if human Inpp5b is 
less efficient at compensating for OCRL than mouse Inpp5b. To determine the effect of this 
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treatment, urine was collected from the mice and analyzed for the presence of low molecular 
weight proteins. Very preliminary results suggest that double knockout mice supplemented with 
a single copy of human Inpp5b had proteinuria very similar to that found in Lowe syndrome, 
while mice containing a single copy of mouse Inpp5b had no discernable proteinuria. These data 
point to a fundamental difference between the expression or function of human and mouse 
Inpp5b and open the door for future study. Whole animal studies using iodinated megalin ligands 
could be performed to examine the ability of megalin to internalize ligands in mice lacking 
OCRL and Inpp5b that are supplemented with a single copy of human Inpp5b. Additionally, the 
mouse studies further validate the prediction that Inpp5b can compensate for lack of OCRL 
activity and increases the probability that experiments designed to study the effect of double 
knockdown in cell lines will yield positive results.   
4.2 THE SITE OF PI5K FUNCTION IN BIOSYNTHETIC TRAFFIC 
My data demonstrate that biosynthetic delivery of HA is sensitive to both increases and 
decreases in cellular PIP2 levels. Furthermore, biosynthetic delivery of HA is also dependent on 
actin polymerization via the PIP2 effector, N-WASP. However, the exact site at which PI5K and 
N-WASP exert their action(s) cannot be elucidated from my studies. While the TGN has long 
been thought to be the site where proteins accumulate when subjected to a low temperature 
block, this has not been exhaustively characterized for all classes of proteins. Indeed, I observed 
that HA may stage at a site other than the Golgi. Briefly, MDCK cells grown on coverslips were 
infected with AVs encoding HA, VSV-G, or YFP-p75 for a short period before staging at 19ºC 
for 3 h followed by fixation and processing for immunofluorescence. Co-staining for each cargo 
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protein and furin (a TGN marker) revealed that both VSV-G and p75 stage in a compartment that 
is coincident with furin; however, HA does not localize the furin-containing compartment and 
does not overlap with YFP-p75 (Figure 4.1). Biochemical studies confirmed that HA expressed 
under similar conditions is largely mature (sialyated) and intracellular. While I was unable to 
positively identify the HA-containing compartment, my data does raise the possibility that the 
PI5K and N-WASP effects occur at a post-TGN site.  
Recent studies indicate that different classes of apical proteins traverse distinct endocytic 
compartments on their way to the apical surface (7). Initially Ang et al. showed that VSV G is 
delivered to the common recycling endosome of polarized epithelial cells before reaching the 
basolateral surface (5). Cresawn et al. further demonstrated that a lipid raft-independent apical 
protein transits through the apical recycling endosome, while lipid raft-dependent proteins move 
through a different compartment accessible to internalized wheat-germ agglutinin (7). These 
studies lend support to a role for endosomes in biosynthetic traffic and raise the possibility that 
PI5K-stimulated comets may be forming on endosomes or endosome-derived vesicles and not 
the TGN. The site at which PI5K and N-WASP function in biosynthetic delivery of HA could be 
tested by performing live cell microscopy in cells expressing fluorescent cargo, actin, and 
different endosomal makers. It would be interesting to compare cells expressing HA and VSV-G, 
as these cargo move through distinct endosomal intermediates. I predict that actin comets would 
primarily associate with vesicular or endosomal structures containing HA but not VSV-G. These 
experiments may help to determine if HA associates with actin comets on vesicles or endosomes. 
While VSV-G has been shown to transit through the common recycling endosome in polarized 
cells, the identity of the endosomal compartment involved in apical delivery of HA is less clear, 
and may represent a previously undescribed apical endosome or a subdomain of a described 
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organelle (7). An alternative method to identify the HA compartment would be to affinity purify 
HA- or VSV-G-containing compartments after a 19ºC stage and perform mass spectrometry 
analysis to identify the components. I predict that N-WASP/Arp2/3 would associate primarily 
with HA-containing carriers/compartments, and that other proteins revealed by the analysis may 
uncover the identity of the compartment. 
What is the role of lipid rafts in apical delivery? Lipid rafts have been proposed to act as 
a platform for recruitment of proteins and for the propagation signaling cascades (270). My data 
revealed that raft-dependent (HA) and raft-independent (p75) apical cargo use different 
mechanisms for apical delivery based on their differential requirement for N-WASP. HA 
associates with lipid rafts and segregates in a different compartment than p75 upon low 
temperature staging (Figure 4.1). These data suggest that because of their sorting signals p-75 
(O-glycan-containing stalk) and HA (transmembrane domain) may be found in diverse lipid 
environments. However, the mechanistic details regarding how rafts mediate apical delivery 
remain elusive. The disputed existence of rafts and discrepancies regarding their size and 
composition make this question difficult to explore. It is likely that a component or distinct 
morphological feature of lipid rafts is responsible for apical sorting of these domains. To answer 
these questions, specialized tools to alter raft composition must be developed so that researchers 
can discover the relationship between composition and function.    
What mechanism do cells use to direct HA-containing cargo carriers to the apical 
surface? Lipid raft-association is not sufficient for apical sorting as lipid rafts and raft-enriched 
cargo do appear at the basolateral cell surface (271;272). Moreover, apically sorted mutants of 
HA exist that are not associated with lipid rafts (20). However, since the sorting information for 
HA is located within the transmembrane domain interaction with a lipid such as PIP2 may be 
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important. In polarized epithelial cells, most of the PIP2 is found at the apical plasma membrane, 
so it is possible that PIP2 synthesis on Golgi localized lipid raft domains could serve as a marker 
to direct that membrane to the apical surface. Concentrated PIP2 at this domain could have a 
twofold effect. The increased negative charge density on the inner leaflet could affect membrane 
curvature leading to bowing of the membrane toward the cytoplasm promoting vesicle budding. 
At this point, a number of scenarios are possible to select the vesicle for apical delivery. 
Recognition of this of this domain by cytosolic factors could be enhanced by the increased local 
PIP2 concentration leading to an overall increased avidity for the membrane. Alternatively, a 
cytosolic protein(s) could recognize both PIP2 and a cargo motif resulting in stronger binding to 
the forming carrier.  
If PI5K is necessary to generate PIP2 on a HA-enriched Golgi domain, then what signal 
recruits the enzyme? It is possible that the abundance of PI5K’s substrate PI4P on the Golgi 
complex could serve to help recruit PI5K. This theory could be tested in vitro by incubating 
purified enzymes with liposomes containing different ratios of lipid species. It is likely that 
recruitment of cytosolic factors such as PI5K and N-WASP rely on coincidence detection 
perhaps with cargo to enhance low affinity interactions. This could be tested using post-TGN 
vesicles immunoisolated from cells either expressing HA or p75. I predict that PI5K and N-
WASP may interact more strongly with HA-containing vesicles, since HA is more frequently 
found on comets. Subsequently, apical delivery of the vesicle probably relies on the concerted 
actions of both the microtubule and actin cytoskeletons. 
How could cells utilize both microtubules and actin direct the polarized delivery of a 
Golgi-derived HA carrier? In polarized epithelial cells microtubules originate from the 
juxtanuclear microtubule organizing center so that their fast growing (plus) ends are directed 
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toward the nucleus and the slow growing (minus) ends are directed toward the apical membrane 
(273). However, a recent study also demonstrated that a large number of plus end microtubules 
are oriented toward the apical pole of polarized cells (274). Therefore, both minus end 
microtubule motors (dyneins or minus end kinesins) or plus end motors (plus end kinesins) could 
be utilized to provide ultimate directionality to carriers propelled from the Golgi by comets. The 
involvement of microtubule motors in apical traffic could be tested by expressing dominant-
negative forms of various microtubule motor proteins and measuring the rate and polarity of 
protein delivery. If microtubules are involved in apical delivery, then disrupting a motor may 
decrease the rate of delivery or aberrant delivery to the basolateral surface. It is possible that 
actin comets are necessary for budding of a raft-enriched cargo carrier from the TGN or 
movement away from the Golgi before contacting and moving along a microtubule for final 
apical delivery. Answering these questions will help us gain a better understanding of the 
underlying mechanisms of apical sorting and delivery. 
 









MDCK cells were infected with adenoviruses encoding YFP-p75, VSV-G, and/or HA for 1 h and 
then incubated for 5 h at 37 °C and 3 h at 19 °C. Cycloheximide was included during the last hour 
at 19 °C. The cells were then fixed and processed for immunofluorescence to detect each marker 
and furin (rows a–c) or to visualize co-expressed HA and YFP-p75 (row d). The insets in row d 
show enlarged versions of the boxed regions. Individual confocal sections and a merged image 
are shown for each condition. Scale bar, 30 µM. The nuclear fluorescence in the YFP-p75 panel in 
row d represents background from the polyclonal anti-GFP used in this sample. In contrast, cells 
in row b were labeled using a monoclonal anti-GFP antibody; in both cases, this protocol was 
used to amplify the fluorescent signal for p75 over that provided by the YFP moiety (see 
"Materials and Methods").  
Figure 4.1 YFP-p75 and HA do not co-localize intracellularly after low temperature staging. 
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4.3 DISTINCT FUNCTIONS OF PI5K ISOFORMS IN POLARIZED EPITHELIAL 
CELLS 
As detailed earlier, there are three isoforms of PI5Ks in mammalian cells. What is the purpose of 
three different enzymes with overlapping substrate specificity? In polarized mouse cortical 
collecting duct (mCCD) cells, PI5KIα is localized exclusively to the apical pole of the cells, 
PI5KIβ is present in both the cytoplasm and at membranes, and PI5KIγ localizes primarily to the 
basolateral surface (Figure 4.2). This raises the possibility that the different isoforms regulate 
functionally-distinct pools of PIP2 in polarized cells. I hypothesize that a given isoform will 
regulate endocytic events at the surface where it localizes. Evidence for this comes from 
published studies by Padron et al., demonstrating that in nonpolarized cells overexpression of 
PI5KIα and PI5KIβ, but not PI5KIγ stimulate transferrin (Tfn) endocytosis (204). In contrast, 
Bairstow et al. showed that in polarized cells, expression of PI5KIγ stimulates Tfn endocytosis 
(275). One interpretation of these contrasting observations is that in nonpolarized cells, the Tfn 
receptor is localized throughout the plasma membrane and PI5KIγ may have minimal influence 
due to the presence of the other two kinase isoforms. However, in polarized cells the Tfn 
receptor is mainly localized to the basolateral membrane where PI5KIγ is found making PI5KIγ 
































 mCCD cells were infected with AVs encoding PI5KIα, PI5KIβ or PI5KIγ and plated 
sparsely on coverslips (top row) or plated onto Transwell filters for 3 days prior to fixation 
and processing for immunofluorescence. Confocal sections show representative kinase 
staining from the apical pole and lateral regions of the cell. The bottom row shows 
deconvolved xz sections from the filter-grown cells. Scale bars represent ~10μm. 
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Whether PI5K isoforms differentially regulate endocytic events at polarized membrane 
domains could be tested by measuring internalization rates of proteins that are endocytosed from 
both the apical and basolateral surfaces. These studies could be performed using mCCD cells, as 
there are reagents available for both detection of endogenous PI5Ks and siRNA knockdown. I 
predict that overexpression of mPI5KIα will increase the endocytosis of proteins from the apical 
surface, whereas basolateral endocytosis will remain unaffected. In preliminary studies, I 
examined the rate of endocytosis of the polymeric immunoglobulin receptor (pIgR), using 125I-
labeled polymeric IgA that has been pre-bound to the cell surface. Consistent with my 
hypothesis, overexpression of mPI5KIα stimulated apical endocytosis of pIgR in mCCD cells, 
but had no effect on basolateral endocytosis of pIgR (Figure 4.3). These studies could be 
furthered by using siRNA to knock down each isoform. I predict that knockdown will have a 
negative effect on endocytosis at either the apical or basolateral surface according to kinase 
localization. The idea that PI5Ks control different endocytic events is appealing and might 
explain the need for multiple isoforms. PI5Ks may exert this differential action by physically 
interacting with or producing distinct pools of PIP2 enabling the recruitment of endocytic 
adaptors and/or CLASPs required for the endocytosis of a given receptor. CLASPs are PIP2-
binding clathrin-associated sorting adaptors that increase the range of signals recognized for 
clathrin-mediated endocytosis of cargo proteins. It is likely that CLASPs utilize coincidence 
detection in order to interact with a receptor more strongly when the receptor is in a PIP2-rich 
environment. This phenomenon may give cells a mechanism to up-regulate the endocytosis of 
certain classes of receptors in response to cell surface changes in PIP2 levels without globally 
affecting all endocytic events (Figure 4.4).   
 

























 mCCD cells were plated onto Transwell filters for 3 days prior to 
infection with AV-Control or PI5KIα and AV-pIgR. The cells were 
allowed to recover for 1 night in 1 ng/ml doxycycline (dox). The day 
after dox washout, I-125 IgA was bound to either the apical surface (A) 
or the basolateral surface (B) for 1 hr on ice and after extensive 
washing IgA was internalized for 0, 2.5, or 5 min. The remaining 
surface counts were stripped using 150mM glycine pH 2.3 and 
internalized counts were determined using a γ-counter.  Error bars 
represent mean +/- std error from n=4 for apical or mean +/- range for 
one representative basolateral experiment.  
 






















Polarized epithelial cells segregate the different PI5K isoforms to different 
surface domains.  Because PI5KIα is localized exclusively to the apical surface, 
it will likely be important for apical endocytic events.  Conversely, the 
basolateral localization of PI5KIγ ideally places it to influence basolateral 
end ocytic events.  PI5 KIβ is fou nd  at bo th su rfaces as well as on internal 
structures and may be involved in endocytosis/recycling or biosynthetic 
trafficking.  This spatial regulation of PIP2 production could be important for 
helping cells specifically upregulate the endocytosis of certain ligands, from 
either surface.   
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4.4 CONCLUDING COMMENTS 
In this dissertation I presented data that help to expand our current knowledge about the 
contribution of PIP2 metabolism and actin polymerization in polarized biosynthetic traffic. The 
discovery that biosynthetic delivery of lipid raft-associated proteins is preferentially sensitive to 
PIP2 solidifies the emerging concept that distinct classes of apical proteins use different 
mechanisms to mediate their apical sorting and trafficking. Furthermore, the identification that 
N-WASP is important not only for HA delivery under PI5K-stimulated conditions, but under 
basal conditions as well firmly places N-WASP as a modulator of biosynthetic pathways. Insight 
gained by these studies regarding regulation of biosynthetic transport is critical to furthering our 
understanding of basic cell physiology and may one day open the door to therapeutic treatments 










* Figure 4.1 from this chapter is published in Guerriero et al. JBC 2008 and was used with the 
permission of the Journal of Biological Chemistry. 
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5.0  MATERIALS AND METHODS 
5.1 DNA,  REPLICATION-DEFECTIVE RECOMBINANT ADENOVIRUSES, AND 
SIRNA OLIGOS 
The α isoform of murine phosphatidylinositol 4-phosphate 5-kinase (PI5K) cloned into the pAdtet 
vector was provided by Dr. Andreas Jeromin (Baylor University). The β isoform of PI5K was the 
kind gift of Dr. Philip Stahl (Washington University). The γ isoform of PI5K was provided Dr. 
Richard Anderson via Dr. Linton Traub (University of Pittsburgh). Constructs encoding myc-
tagged W and WA domains of WAVE1 were generous gifts of Dr. Dorothy Schafer and Dr. 
James Casanova (University of Virginia). Fluorescent protein-tagged actin constructs were 
provided by Dr. Ronald Montelaro (University of Pittsburgh). The generation and purification of 
replication-defective recombinant adenoviruses (AVs) encoding tetracycline-repressible 
influenza HA (Japan serotype), VSV-G, and a control virus (encoding the influenza Rostock M2 
coding sequence in the reverse orientation) has been previously described (50;236). AVs 
encoding PI5K α, β,γ and human OCRL (both wild type and the phosphatase-deficient mutant 
R483G; constructs provided by Robert Nussbaum, MD University of California, San Franscisco) 
were generated using similar methods. AV encoding p75NTR was provided by Dr. Enrique 
Rodriguez-Boulan (Weill Medical College) with permission from Dr. Moses Chao, and AV-W 
and WA were kind gifts of Dr. James Casanova (University of Virginia).  
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Firefly luciferase siRNA was used as a control for siRNA experiments; 5’-
GAATATTGTTGCACGATTT-3’. The sequence for the OCRL siRNA was obtained from Dr. 
Philip Majerus’ lab (Dr. Alex Ungewickell) and matches human, mouse, and canine OCRL; 5’-
GGTTCCCTGCCATTTTTCA-3’. An siRNA targeting canine N-WASP was based on a 
published siRNA targeting rat N-WASP; 5’-GGCGAGACCCCCCAAATGC-3’ (238). The 
OCRL and N-WASP siRNAs have an intentional mismatch at the 3’ end of the sense strand 
which creates a bias for the antisense strand entering the RNA-induced silencing complex 
(RISC) and increases the rate of target mRNA degradation (205-207). All siRNAs were 
purchased from Dharmacon and were reconstituted in Dharmacon’s 1X siRNA buffer at a 
concentration of 1 µg/µl (Thermo Scientific, Lafayette, CO).  
5.2 ANTIBODIES, REAGENTS AND IMMUNOBLOTTING 
Immunoprecipitation (IP) or immunofluorescence (IF) of HA, VSV-G, or p75 was performed 
using supernatants from cultured hybridomas (Fc125 from Dr. Thomas Braciale, University of 
Virginia; 8G5 from Dr. Douglas Lyles, Wake Forest University  (276); and MA 20.1 from Dr. 
Enrique Rodriguez-Boulan, Weill Medical College, respectively). Mouse anti-OCRL ascities for 
western blotting and IF were obtained from Dr. Sharon Suchy and Dr. Robert Nussbaum. Mouse 
anti-giantin was a gift from Dr. Adam Lindstet (Carnegie Mellon University). Rabbit anti-furin 
was purchased from Affinity BioReagents (Golden, CO). Mouse anti-HA-tag was obtained from 
Covance (Berkley, CA) and rat anti-HA-tag was obtained from Roche (Indianapolis, IN). Rabbit 
monoclonal anti-N-WASP was obtained from Cell Signalling Technology (Danvers, MA). 
Rabbit anti-GFP was obtained from Invitrogen (Molecular Probes, Carlsbad, CA). Mouse anti-β-
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actin, cytochalasin D, nocodazole, n-butanol, t-butanol, and phorbol myristate acetate (PMA) 
were obtained from Sigma (St. Louis, MO). Wiskostatin was obtained from Calbiochem (San 
Diego, CA). 
Blotting samples were resolved on BioRad 4-15% Criterion precast gels and transferred 
to nitrocellulose (GE Healthcare, Piscataway, NJ) using the Criterion transfer apparatus (BioRad, 
Hercules, CA). Nonspecific background was reduced by incubating blots for 1 h in PBS 
containing 5% non-fat dry milk. Blots were then incubated with 1º antibody for 1-2 h in PBS 
containing 1% milk, washed with PBS, incubated with a 2º anti-HRP antibody for 1 hr, washed, 
and incubated with Pierce SuperSignal (Thermo Scientific, Rockford, IL). Exposures were taken 
using a BioRad VersaDoc and quantitated using Quantity One software (BioRad).  
5.3 CELL LINES  
Madin-Darby canine kidney (MDCK) type II cells stably expressing the tetracycline 
transactivator (TA) and the rabbit pIgR were cultured in modified Eagle's medium (Sigma) 
supplemented with 10% fetal bovine serum (FBS) (Atlanta Biologicals). Mouse cortical 
collecting duct (mCCD) cells were cultured in 1:1 low glucose Dulbecco’s Modified Eagles’s 
Medium (DMEM) (Sigma) and Ham’s F12 (Gibco) supplemented with 60 nM sodium selenate, 
5 µg/ml transferrin, 2 mM glutamine, 50 nM dexamethasone, 1 nM triiodothyronine, 10 ng/ml 
epidermal growth factor, 5 µg/ml insulin, 20 mM D-glucose, 20 mM HEPES and 2% heat-
inactivated FBS (277). For measurements of intra-Golgi transport, kinetics of surface delivery, 
surface polarity, transcytosis, and endocytosis; cells were seeded at superconfluence in 12-mm 
Transwells (0.4-µm pore; Costar, Cambridge, MA) for 2–4 days prior to infection with 
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recombinant AVs. For IgA transcytosis and endocytosis experiments, pIgR expression was 
enhanced by incubation with 2 mM sodium butyrate for 16 h. Experiments were performed the 
following day. 
HK2 cells were obtained from ATCC and maintained in DMEM:F12 (Sigma) 
supplemented with 5 µg/ml insulin and 50 nM dexamethasone. Cells were grown in 10 cm 
culture dishes (Falcon) and plated onto 12-well dishes (Corning) for experimentation.  
5.4 ADENOVIRAL INFECTION 
On the day prior to the experiment cells were washed two times with PBS supplemented with 
1mM MgCl2 (PBS-Mg2+). Cells were then incubated with the intended adenovirus (AV) at the 
following multiplicity of infection (m.o.i.) (control AV, AV-PI5K, AV-W,  AV-WA, AV-OCRL, 
and AV-OCRL mutant, m.o.i. 100–250; AV-TA, AV-pIgR, AV-HA, AV-p75, AV-YFP-p75,  
and AV-VSV-G, m.o.i. 25–50) as described in Henkel et al. 1998 (236). Following the infection 
cells were rinsed with PBS-Mg2+ before being returned to culture in normal growth medium. 
Experiments were performed the following day. CCD cells were allowed to recover for 1 night 
following infection and virus expression was repressing by including 1 ng/ml DOX in their 
medium. 
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5.5 INDIRECT IMMUNOFLUORESCENCE 
MDCK cells grown on Transwell filters or coverslips were infected with AVs at the indicated 
m.o.i. The following day, cells were rinsed with PBS, fixed in 3.7% formaldehyde, rinsed with 
PBS containing 10 mM glycine (PBS-G), and then permeabilized with 0.5% Triton X-100 in 
PBS-G for 3 min at room temperature. After washing, nonspecific binding sites were blocked by 
incubation for 5 min in PBS-G containing 0.25% (w/v) ovalbumin. Coverslips were incubated for 
30 min with monoclonal anti-HA tag antibody (1:500 dilution; Covance) followed by washing in 
blocking buffer. Cells were then incubated for 30 min with secondary antibodies Alexa Fluor 
goat anti-mouse 488 (1:500; Invitrogen, Carlsbad, CA). Rhodamine phalloidin (1:80; Invitrogen, 
Molecular Probes) was included in this step where indicated. After extensive washing, coverslips 
or filters were mounted onto glass slides.  
Filter-grown MDCK or mCCD cells were fixed with formaldehyde using a pH-shift 
protocol with paraformaldyhyde in a cacodylate buffer. For the pH-shift protocol, samples were 
treated as described in Apodaca et al. 1994  (278). Alternatively, cells were washed by dipping 
into warm PBS, and samples were fixed for 15 min in 4% paraformaldehyde diluted into 100 
mM sodium cacodylate at 37ºC. The fixation was quenched using 20 mM glycine and 75 mM 
NH4Cl in PBS, followed by 10 min in 0.1% TX-100, and then blocking in PBS with 1% 
BSA/0.1% saponin. Images were captured using a Leica TCS-SL confocal microscope equipped 
with argon and green and red helium neon lasers (Leica, Dearfield, IL). Images were taken with a 
100X (1.4 numerical aperture (NA)) plan apochromat oil objective. TIFF images were processed 
using Adobe Photoshop (Adobe, San Jose, CA). Some fixed samples and all live samples were 
imaged using an Olympus IX-81 inverted microscope equipped with a Perkin Elmer spinning 
disc confocal. Images were taken with either an Olympus 60X PlanApo (NA 1.40) or a 100X 
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UPlanApo (NA 1.35) oil immersion objective. Live images were captured and analyzed using 
Metamorph imaging software (Molecular Devices, Downington, PA).  
5.6 INTRACELLULAR TRANSPORT AND CELL SURFACE DELIVERY ASSAYS 
AV-infected filter-grown MDCK cells were starved for 30 min and radiolabeled for 5–10 min 
(for endoglycosidase H (endo H) kinetics) or 15–20 min ( for TGN to surface delivery) on drops 
containing 1 mCi/ml Tran-35S-label® (MP Biomedicals, Irvine, CA). To measure endo H 
kinetics, cells were chased in bicarbonate-free modified Eagle's medium for the indicated periods, 
solubilized, and HA was IPed as previously described in Henkel et al. 1998 (236). After 
collection of antibody-antigen complexes, samples were eluted, divided in half, and mock-treated 
or treated overnight with endo H prior to electrophoresis on 10% SDS-PAGE gels. To measure 
TGN-to- cell surface delivery, radiolabeled cells were chased at 19ºC for 2 h unless otherwise 
indicated to stage newly synthesized membrane proteins in the TGN. The cells were then rapidly 
warmed to 32°C or 37°C as indicated. Apical delivery of HA was measured by trypsinization as 
described in Henkel et al. 2000 (232). Briefly, after each time point samples were rapidly cooled 
to 4°C, by a wash with cold media. Samples were then incubated in cold media supplemented 
with TPCK-treated trypsin for 30 min followed by two 10 min washes in media supplemented 
with soy bean trypsin inhibitor. Basolateral delivery of VSV-G was quantitated using domain 
selective biotinylation as described in Ref.  (279). Briefly, after each time point cells were 
washed thoroughly with cold PBS containing 1mM MgCl2 and 1mM CaCl2. The apical or 
basolateral surface was biotinylated twice for 10 min each with sulfo-NHS-SS-biotin (0.5 
mg/ml;Cat # 21331, Thermo-Fisher, Pierce) in TEA-buffered saline, pH 7.6. The biotinylation 
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reaction was quenched by incubation in media containing 10% FBS. To quantitate surface 
delivery of p75NTR or HA delivery in OCRL-expressing samples, cells were radiolabeled on 25-
µl drops of sulfate-free medium containing 100 µCi of [35S]sulfate at 18°C and the rate of surface 
delivery was assessed using domain selective biotinylation upon subsequent warm-up to 37°C 
(280).  
5.7 VISUALIZATION AND QUANTITATION OF ACTIN COMETS 
MDCK cells (2 x 105) were seeded on Bioptech 0.17-mm ΔT dishes (Bioptech Inc., Butler, PA). 
The following day cells were infected with AVs (m.o.i. 100–250) encoding the indicated 
proteins, and incubated overnight with 0.25 ng/ml doxycycline (DOX) to partially suppress 
protein expression. The following morning DOX was removed by thorough washing. Cells were 
then pressure-injected with cDNA encoding GFP- or YFP-actin and were returned to culture for 5 
h. Following that time the cells were imaged on an Olympus IX81 microscope using a 100 X 
Olympus UPlanApo objective (numerical aperture 1.35). Random fields containing cells 
expressing fluorescent actin were imaged every 2 s for 3-4 min. Data were analyzed using 
acquisition software (Slidebook or Metamorph) to determine the percentage of cells with comets. 
Stable cells lines expressing fluorescent protein-tagged actin were generated using Lipofectamine 
2000 and mixed populations were isolated by selection in G418. These cells were infected with 
AV-PI5K where indicated and used for the quantification of actin comets in cells treated with 
PMA PMA (5 µg/ml), cytochalasin D (25 µg/ml), n-butanol (1% v/v), t-butanol (1% v/v), or 
OCRL siRNA. 
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5.8 IGA TRANSCYTOSIS 
Filter-grown MDCK cells stably expressing pIgR were treated with wiskostatin at the indicated 
time and concentration. Samples were washed thoroughly with cold MEM + 0.6% BSA and then 
placed on drops of MEM containing 5 µl dimeric 125I-IgA (~ 0.8-1.5 x 106 counts/µl) at 37ºC for 
10 min. Next, the cells were washed for 5 min to remove nonspecifically bound 125I-IgA. Apical 
medium was collected over a 120’ time course and the secreted and cell-associated counts per 
minute were determined and used to calculate the percent IgA transcytosed over time.   
5.9 IGA ENDOCYTOSIS 
Filter-grown mCCD cells were infected with AV-pIgR and AV-transactivator and either a 
control AV or AV-mPI5KIα. Cells were k ep t in 1  ng /ml DOX overn ight to  allow the cells to  
recover prior to protein expression. The next day the cells were washed 4 times with media to 
remove the DOX and were fed with media containing 2% sodium butyrate to induce expression 
of pIgR. The following day, samples were washed thoroughly with cold MEM containing 0.6% 
BSA to block nonspecific binding sites. Samples were then placed on drops of MEM containing 
5 µl dimeric IgA (for basolateral endocytosis) or incubated with iodinated IgA apically (for 
apical endocytosis) for 1 h at 4ºC. Samples were washed extensively to remove nonspecific IgA 
and then warmed for 0, 2.5 or 5 min. At each time point the samples were rapidly cooled and 
placed into media containing 10 µg/ml TPCK-treated trypsin to remove remaining surface IgA. 
The samples were then placed in cold PBS containing 150 mM glycine pH 2.3 to further strip 
IgA from the cell surface. The apical or basolateral media, the trypsin wash, the glycine wash, 
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and the cells were collected and counted in a γ-counter to determine the relative percentage cell-
associated IgA over the time course.    
5.10 SIRNA TREATEMENT OF MDCK AND HK2 CELLS 
MDCK or HK 2 cells were grown to 50% confluence prior to trypisnization to prepare for 
electroporation. Cells were counted and reuspended at a density of 1 x 106 cells/100 µl Amaxa 
solution mix (see below). Cells were mixed with 5 µg siRNA/1 x 106 cells and electroporated 
using Amaxa program T-020 in a single cuvette. Cells were immediately plated onto Transwell 
filters at a density of 0.5 x 106 cells/filter and the media was changed the following morning to 
remove cell debris. Knockdown was assayed using western blot 3 days after electroporation. The 
recipe for the Amaxa solutions was obtained from Dr. Alex Ungewickell. For Amaxa solution I, 
a solution of 36 µM ATP and 59 µM MgCl2 were mixed with 10 ml dH2O, filter sterilized, and 
stored at -80ºC in 20 µl aliquots. Amaxa solution II contains 440 µM KH2PO4, 70 µM NaHCO3, 
and 11 µM D-Glucose which was dissolved in 500 ml dH2O, adjusted to pH 7.4 with NaOH, 
filter sterilized, and stored in 1 ml aliquots. Immediately before cell resuspension, aliquots of 
each solution were mixed together and kept on ice.  
5.11 DETERMINATION OF CELLULAR ATP LEVELS 
MDCK cells were plated at 50,000 cells/well in 12-well dishes (Costar). The following day the 
cells were treated for 0–1 h with vehicle, wiskostatin, or 2% sodium azide (as a positive control) 
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and then solubilized by the method described in Yang et al. (281). Briefly, cells were washed 
twice with PBS followed by the addition of 1 ml of boiling distilled H2O to each well, the cells 
were removed by pipetting, and the samples were centrifuged at 4ºC for 5 min at 13,000 rpm to 
pellet debris. To assess the reversibility of drug treatment, cells were rinsed three times and 
incubated in fresh drug-free medium for 30 min before harvesting. To determine cellular ATP 
levels after treatment, 20 µl of each lysate was mixed with 100 µl of rLuciferase/Luciferin 
(Promega) and relative luminescence units were measured with a luminometer (Turner Designs 
TD-20.20). The ATP concentration in each sample was calculated by comparing the 
experimental values to a standard curve constructed with known concentrations of ATP and 
plotted as the percentage of control values obtained for mock-treated samples. Raw data were log 
transformed and analyzed by paired t-test. A P value of <0.05 was considered statistically 
different. 
5.12 VISUALIZATION OF CARGO ASSOCIATED WITH ACTIN COMETS 
MDCK cells (3 x 105) were seeded onto coverslips in 12-well dishes. The following day the cells 
were co-infected with AVs encoding HA and either PI5K or control AV. After 8 h at 37ºC, the 
cells were incubated at 19ºC for 2.5 h to stage HA in the TGN. Dishes were then warmed to 37ºC 
for 0 or 30 min before fixation and processing for indirect immunofluorescence to detect HA, 
PI5K, and actin. 
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